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ABSTRACT 
 
 Neonatal calves are immune-suppressed and susceptible to infection by 
Mycobacterium avium, subsp. paratuberculosis (MAP).  Dietary colostrum and fat-
soluble vitamins were hypothesized to enable positive regulation of microbial interactions 
through immunity.  Thus, thirty Holstein calves were randomly assigned to experimental 
treatments: 1) colostrum deprived (CD), no vitamins; 2) colostrum replacer (CR), no 
vitamins; 3) CR, vitamin A; 4) CR, vitamin D3; 5) CR, vitamin E; 6) CR, vitamins A, D3, 
E, and were fed pasteurized whole milk (PWM) for 14 d.  Calves were orally inoculated 
with 10
8
 cfu of Mycobacterium avium subsp. paratuberculosis (MAP) per dose on d 1 
and 3 of age.  Blood was collected at birth and on d 1, 7, and 14, and feces were collected 
on d 7.  Calves were euthanized on d 14 for collection of intestinal contents, mucosal 
scrapings, and tissues.  Serum was assayed for immunoglobulin G1, inflammatory acute 
phase proteins, and metabolites of vitamins A, D3, and E, and peripheral and lymphoid 
mononuclear leukocytes were characterized by flow cytometry.  The immune status and 
health of calves was related to intestinal microbial community structure. 
Non-supplemented calves fed PWM were vitamin D and E deficient, and 
supplementation with colostrum and vitamins D3 and E decreased the likelihood of 
scours.  Colostrum-deprived calves failed to passively acquire IgG1 and haptoglobin and 
exhibited decreased peripheral abundance of γδ T cells, which indicated TH1-biased 
immunity.  TH1-like peripheral responses to PHA were observed in vitro, but TH2-like 
lymphoid responses to MAP in vitro included γδ T cell proliferation.  Shedding of MAP 
was observed at d 7, and MAP colonized the distal small intestine in low abundance.  
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Nutritional treatments affected microbial community structure in a manner consistent 
with clinical observations of health.  Microbial communities of cecum and colon in CD 
calves were richer than in CR calves, and mucosal communities in the spiral colon of CD 
calves exhibited dysbiosis by harboring increased Proteobacteria and decreased 
Bacteroidetes.  Disparity between lumen and mucosal microbial communities was related 
to decreased health.  Thus, aberrant regulation of immunity upstream of the large 
intestine may affect MAP infection and potentiate opportunism in the cecum and colon.  
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CHAPTER 1 
 A REVIEW OF IMMUNE DEVELOPMENT, POST-NATAL NUTRITION, AND 
MICROBIAL COLONIZATION IN THE BOVINE NEONATE  
 
 
Introduction 
The neonatal dairy calf is born immunologically immature and is highly 
susceptible to infectious diseases.  The immune status of the neonate is affected by 
maternal influences during the prenatal stage of development, lactocrine influences 
during neonatal life, and other post-natal nutritional influences such as dietary energy and 
micronutrient adequacy.  Non-nutritive compounds in colostrum and milk confer passive 
immune protection to the neonate and may further contribute to the development of 
microbial commensalism at the intestinal epithelial borders.  Understanding the 
mechanisms by which the post-natal diet complements pre-natal influences on 
physiologic systems is important for fostering optimal development of growth, immunity, 
and microbial commensalism in the pre-weaned calf.  This review explores the maternal-
prenatal, lactocrine, and post-natal nutritional influences on immune development in the 
calf and subsequent microbial colonization of the intestinal mucosa for the establishment 
of stable commensal relationships between cattle and their microbial symbionts. 
Maternal-Prenatal Influences 
  Fetal development occurs in the sterile uterine environment (Møller et al, 1995).  
Parturition, at which time the fetus transitions from complete protection from microbial 
exposure to antigenic bombardment at all tissues, represents significant immunological 
upheaval.  By the time of parturition, the fetus possesses a complete repertoire of innate 
immune functions and all anatomical components of the acquired immune system 
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(Holsapple et al, 2003).  Immune cells first differentiate during embryonic development 
as pluripotential hematopoietic stem cells (Holsapple et al, 2003; Weisman 2000).  Fetal 
hematopoietic stem cells subsequently differentiate as lineage restricted stem cells during 
migration, first to liver and spleen, and ultimately to bone marrow and the thymus during 
late gestation (Holsapple et al, 2003; Cumano et al, 2001; Cumano and Godin, 2001).  
Proliferative progenitor cells in the bone marrow and thymus expand into the various 
lineages of circulating leukocytes; bone marrow becomes the primary location of 
hematopoiesis, whereas lymphocytes differentiate from progenitor cells in both the bone 
marrow and the thymus.   
  As reviewed by Abbas et al (2012),
 
lymphocyte progenitors mature into dendritic, 
natural killer, B, and T cells.  B and T cells undergo several stages of differentiation, with 
the commitment to their respective lineages occurring during T cell receptor (TcR) or 
immunoglobulin gene rearrangement to generate diverse antigen receptors.  Lymphocyte 
progenitors commit to the B lineage by random recombination of one Ig VH gene 
segment with one diversity (D) segment and one joining (J) segment to form the heavy 
chain locus.  Similarly, the T cell β chain randomly recombines with D and J segments 
and is expressed on the cell surface as part of the pre-TcR complex.  T cells further 
undergo positive and negative selection for MHC and non-self interactions, respectively.  
The T cell receptor complex contains TcR and accessory molecules that enable signal 
propagation and interaction with antigen presenting cells.  Most T cells express α and β 
subunits in the TcR, but a subset of cells alternatively expresses γ and δ subunits.  T 
helper cells (TH) express cluster of differentiation (CD) 4, which facilitates interaction 
with class II major histocompatibility complex (MHC) of antigen presenting cells, 
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whereas cytotoxic T cells express CD8 for interaction with class I MHC.  Additionally, T 
and B cells express CD3 or Igα and Igβ, respectively, in their receptor complexes for 
signal propagation. 
  CD4
+
 T cells mediate activation of humoral and cell-mediated adaptive immune 
responses (Abbas et al, 2012).  Antigen presentation in the context of IL-12 provokes TH 
cells to differentiate to the TH1 subset and express IFN-γ, along with IL-1, IL-6, and 
TNF-α, for increased phagocyte activity and stimulation of inflammation (Chase et al, 
2008; Wilder, 1995; Elenkov, 2004; Abbas et al, 2012).  Antigen presentation in the 
absence of IL-12 is associated with TH differentiation to the TH2 subset to produce anti-
inflammatory IL-4.  TH2 cells primarily interact with B cells to promote differentiation 
and class switching.  
  In humans, which have similar gestational length to cattle, lymphocyte progenitor 
cells begin migration to the thymus at approximately 9 weeks after conception, and 
Peyer’s patches appear in the intestinal lamina propria beginning at week 11 of gestation 
(Holsapple et al, 2003; Royo et al, 1987).  In the bovine fetus, IFNγ has been induced 
within 9 weeks of gestation, in agreement with the timeline of human lymphopoiesis 
(Chase et al, 2008).  Fetal bovine lymphocytes traffic heavily to lymphoid tissues within 
the final month of gestation, and innate responses by neutrophils and macrophages are 
fully developed in the final trimester (Chase et al, 2008; Charleston et al, 2001).  
  Increased fetal cortisol and decreased maternal progesterone collectively suppress 
TH1 immunity before parturition and during the early post-natal period (Chase et al, 
2008).  Glucocorticoids, which include cortisol, generally act upon nuclear receptors of 
antigen presenting cells to suppress IL-12 (Visser et al, 1998).  Glucocorticoids also have 
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been shown to directly suppress IL-1 and IL-2 through the immune-hypothalamic-
pituitary-adrenal axis (Wilder, 1995; Bateman et al, 1989).  Corticotropin releasing 
hormone (CRH) from the hypothalamus stimulates adrenocorticotropin release from the 
pituitary gland, which in turn stimulates adrenal corticosteroid release.  CRH also directly 
activates the sympathetic nervous system for norepinephrine synthesis.  Corticosteroids 
and norepinephrine subsequently downregulate targeted cytokines in immune cells 
(Wilder, 1995; Bateman et al, 1989).  Interestingly, thymic expression of neuroendocrine 
hormones has been characterized to include CRH for activation of the pituitary-adrenal 
axis and subsequent release of adrenal corticosteroids, although systemic contributions of 
thymic CRH relative to hypothalamic CRH have not been well described (Wilder, 1995).  
As fetal cortisol increases during late gestation, progesterone, which is a glucocorticoid 
receptor antagonist, decreases in concentration during late stage pregnancy and allows for 
increased glucocorticoid influence (Bateman et al, 1989).  Thus, the neonatal calf is born 
in a hormonally induced, TH2-biased state, characterized by IL-12 suppression that 
stimulates humoral immunity (Elenkov, 2004).  Mature, endogenous, B lymphocytes, 
however, are of low abundance in the neonatal calf, and effector B lymphocytes and 
plasma cells are absent, so TH2 signaling does not generate effective humoral immunity 
(Chase et al, 2008).  Thus, pre-natal hormonal influences induce tolerance via a TH2 
cytokine bias that leads to ineffective humoral immunity. 
  Other anti-inflammatory conditions have been observed in neonatal mice (Elahi et 
al, 2013).  Adult murine splenocytes transferred to neonatal mice poorly expressed TNF-
α.  Similarly, expression of both TNF-α and IL-6 by adult B and T lymphocytes, dendritic 
cells, and macrophages was inhibited by co-culture with neonatal splenocytes in the same 
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study (Elahi et al, 2013).  Whereas adult murine splenocytes were primarily cells of 
immune lineage, immune cells were less represented among neonatal splenocytes.  
Instead, CD71
+ 
(transferrin receptor) cells of erythroid lineage were abundant and were 
shown to impair neonatal immune cell activation via arginine depletion.  A similar 
CD71
+
 erythroid lineage identified in human cord blood was similarly suppressive (Elahi 
et al, 2013), and transferrin receptor homologous to the human receptor has been purified 
from bovine lymphocytes (Naessens and Davis, 1996).  Existence of the CD71
+
 
immunosuppressive erythroid lineage has not been explored in bovine cord blood or 
neonatal splenocytes, but represents a secondary potential mechanism for TH1 
suppression in the neonate.  
  Suppression of TH1 immunity to accommodate massive bacterial antigen 
exposure upon parturition increases reliance upon humoral immunity to defend against 
pathogens.  However, because the fetus develops in a sterile environment, the neonate has 
no population of effector B or T lymphocytes or circulating antibody of endogenous 
origin.  In species with hemochorial placentae, the fetus acquires IgG1 transplacentally 
during the final trimester of gestation (Palmeira et al, 2011).  Syncytiotrophoblasts in the 
chorionic epithelium directly contact maternal capillary blood and endocytose maternal 
IgG1.  The chorionic trophoblast then fuses with the fetal endothelium to release antibody 
into fetal circulation.  Endosomes within syncytiotrophoblasts contain the neonatal Fc 
receptor (FcRn) that binds IgG1 in a pH dependent manner and protects the molecule 
from lysosomal degradation.  IgG1 further traverses the intravillous stromal space and the 
fetal capillary endothelium into fetal circulation.  In other species, such as ruminants with 
synepitheliochorial placentae, the uterine epithelium lies between the maternal capillary 
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endothelium and the chorionic epithelium and does not allow for transplacental passive 
transfer of antibody (Borghesi et al, 2014).  Thus, the neonatal calf is born 
agammaglobulinemic and highly susceptible to infection. 
Colostrum Supplementation 
  Although born without circulating antibody, neonatal ruminants passively acquire 
maternal IgG1 antibody via colostrum.  Like placental syncytiotrophoblasts, bovine 
mammary acinar cells of the alveolar epithelium express FcRn both apically and 
basolaterally to facilitate transcytotic secretion of IgG1 into colostrum before parturition 
(Mayer et al, 2005; Stelwagen et al, 2009).  Secretion of IgG1 into colostrum begins 4-6 
weeks prepartum under the primary influence of increased maternal estrogen (Stelwagen 
et al, 2009).  After parturition, increased prolactin coincides with cessation of basolateral 
FcRn expression and transepithelial IgG transport in the mammary gland (Mayer et al, 
2005; Stelwagen et al, 2009).  IgG1 accumulates in the mammary gland during 
colostrogenesis, and may range from 10-79 g/L in colostrum at the time of parturition 
(Barrington et al, 2001; Kehoe et al, 2007). 
  Passive transfer of maternal antibody through colostrum has been intensively 
studied and reviewed (Weaver et al, 2000).  FcRn is expressed in the neonatal jejunal 
epithelium to facilitate pinocytosis of IgG1 during the first 24 h of life, and other 
macromolecules may be non-specifically absorbed (Weaver et al, 2000; Broughton and 
Lecce, 1970).  Following transepithelial absorption from the diet, IgG1 circulates 
systemically and reaches the epithelial barriers of the lung and intestine to interact with 
microbial antigens (Besser, 1993).  Calves that do not consume colostrum fail to acquire 
IgG1 in serum within 24 h in a condition termed failure of passive transfer (FPT).  
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Attempts have been made to arbitrarily define FPT by the IgG1 concentration in serum 
that is required to decrease morbidity and mortality among dairy calves.   Robison et al 
(1988) reported greater mortality and lower growth rate when Holstein heifers failed to 
acquire 12.0 mg of IgG in serum by 48 hours post-partum.  Besser et al (1991) later 
defined FPT at 10.0 mg/mL and determined that calves were likely to exceed that 
threshold when fed greater than 100 g IgG1 at first feeding.  The threshold for disease 
prevention largely depends on environmental pathogen reservoirs and nutritional 
influences on innate immunity, and thus cannot be absolutely defined.  Serum IgG1 of 
15.0 mg/mL or total protein of 5.5 g/dL is thought to be the threshold beyond which no 
further improvement to calf health can be made via passive immunoglobulin transfer 
(Weaver et al, 2000).  Baseline mortality rates, however, are identified even among 
cohorts with serum total protein greater than that 5.5 g/dL, and many calves exhibiting 
complete FPT with < 2.0 mg/mL will survive early life (Weaver et al, 2000).  Therefore, 
contributions to the neonatal immune system other than passively acquired antibody are 
important for calf health and affect survival. 
  Indeed, colostrum contains a multitude of serum-derived components including 
immunologically active cells and molecules (Stelwagen et al, 2009).  Mammary epithelial 
tight junctions are more permeable during colostrogenesis than during early lactation 
(Thompson, 1996), and the permeable state is assumed to allow non-specific passage of 
serum components into pre-parturition mammary secretions.  Thus, whereas FcRn 
facilitates active transport of IgG1 into the alveoli, increased tight junction permeability 
facilitates passive transport of leukocytes and serum proteins into colostrum.  Neutrophils 
and macrophages are especially present among somatic cells in colostrum (Stelwagen et 
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al, 2009); their presence may compensate for decreased phagocytic infiltration into 
neonatal tissues induced by the maternal TH2 bias.  Colostrum and milk contain increased 
numbers of suppressor-CD8
+
 and cytotoxic-γδ T lymphocytes that may cooperatively 
protect mammary epithelial tissue during the time around parturition (Sordillo et al, 
1997).  IL-4 secreted into colostrum by suppressor CD8
+
 cells likely contributes to 
passively maintaining the neonatal TH2 bias after parturition.   
  Innate proteins such as lactoferrin and complement work in concert with 
immunoglobulin to enhance bacterial killing and are also present in colostrum (Chase et 
al, 2008; Sordillo et al, 1997).  Lactoferrin binds iron to decrease availability of the metal 
to microbes and subsequently inhibit microbial synthesis of superoxide dismutase, an 
enzyme that enhances evasion of phagolysis.  As reviewed by Janeway et al
 
(2001), 
complement protein C1q binds IgG agglutinated pathogens to initiate the classical 
pathway for direct bacterial killing, whereas C3 binds directly to pathogen surfaces to 
initiate the alternative complement pathway.  The pathways converge at C3 convertase, 
which is cleaved to C3a and C3b; C3a is a pro-inflammatory mediator whereas C3b 
remains bound to the pathogen as an opsonin.  Downstream convergence of C3b with 
convertase initiates the membrane attack complex for direct microbial killing.  
  The known immune functions of colostral compounds are consistent with 
expected compensation for the TH2 bias that suppresses neonatal immunity.  Maternal 
neutrophils and macrophages infiltrate colostrum and subsequently arrive at neonatal 
intestinal epithelial tissue while infiltration of endogenous phagocytic cells is less 
developed.  γδ T cells especially protect epithelial tissues while CD4+-mediated TH1 
immunity is suppressed by CD8
+
 suppressor cells (Sordillo et al, 1997).  Suppressed TH1 
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responses allow for enhanced phagocytosis and antigen processing without overt 
inflammatory responses.  Increased serum amyloid A without coincidence of acute 
clinical distress, however, has been documented within 7 d of age in colostrum-replete 
calves (Krueger et al, 2014) and suggests controlled inflammation through TH1 signaling.  
γδ T-cells are abundant in newborn calves and may facilitate early immune regulation 
through IFN-γ (Taschuk and Griebel, 2012; Romero et al, 2014; Buisine et al, 1998; 
Ramsburg et al, 2003).   Antibody isotypes are dominated by IgG and enhanced by 
complement for opsonization, whereas IgA, which agglutinates rather than opsonizes, is 
less present in the intestinal lumen (Sordillo et al, 1997).  The nature of the conglomerate 
of serum-derived compounds that migrates to colostrum for early stimulation of the 
neonate suggests participation in immune development, rather than just passive 
protection.  Thus, the need for colostrum by the neonatal calf is well supported. 
Feeding Pasteurized Whole Milk 
  Colostrum supplementation at birth has been the most intensively studied and 
commercially adopted means of disease prevention in young calves.  However, even 
among calves that acquire greater than 5.5 g/dL serum total protein, a basal mortality rate 
still exists that is attributed to environmental pathogen reservoirs and the homeostatic 
condition of the animal, which is primarily influenced by nutrition (Weaver et al, 2000).  
Although newborn calves are introduced to solid feed within the first of week of life to 
promote rumen papillae growth, they are fed a mostly liquid diet during the pre-ruminant 
phase of development.  Evidence shows that rumen development can be accelerated by 
dry feed intake during the pre-weaning period to support weaning as early as 4 weeks of 
age (Anderson et al, 1987).  Growth during the pre-ruminant phase of development, 
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however, is maximal when calves are fed milk or milk replacer ad libitum and is 
positively correlated to milk production during the first lactation and throughout maturity 
(Jasper and Weary, 2002; Soberon et al, 2012).  Thus, interest has been renewed in 
meeting the nutritional requirements for maximal growth of the pre-ruminant calf through 
liquid feeds, such as milk replacer, whole milk, or whole milk supplemented with a milk 
balancer.  On a dry matter basis, whole milk contains approximately 24% crude protein 
and 28% fat with about 128 g/L total solids.  Milk replacers vary in crude protein and fat 
inclusions, ranging from 20% CP / 20% fat to 28% CP / 10% fat.  Formulations may 
include increased protein to support greater growth or increased fat to support greater 
maintenance requirements during cold stress (Scibilia et al, 1987; Blome et al, 2003).  
Poor emulsification of milk replacer fats can cause intestinal distress and disturbances to 
growth and health of calves (Radostits and Bell, 1970); fat is rarely included in milk 
replacer formulations at greater than 20% dry matter.   
  Whole milk is in ready supply on most commercial U.S. dairy farms that discard 
milk harvested from periparturient cows and those with mastitis, or that are in withdrawal 
from antibiotic treatment.  Discarded whole milk represents a monetary loss to producers 
and an opportunity to recoup value by feeding it to calves after pasteurization.  
Pasteurized whole milk (PWM) fed to calves receives little nutritive evaluation because 
whole milk is the natural diet for mammalian offspring and hence considered 
nutritionally complete.   
  Effects of varied amounts of milk intake on young calf performance have been 
studied extensively.  Marshall and Smith (1970) demonstrated maximal body weight gain 
when calves were fed whole milk ad libitum compared with calves fed ad libitum skim 
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milk, ad libitum colostrum, or whole milk at a rate of 9% of body weight.  Huber et al 
(1984) demonstrated increased weight gain but adverse health effects when calves were 
fed whole milk at 17% of body weight against controls that were fed 10% of body weight 
according to conventional practice.  Contrarily, Appleby et al (2001) observed increased 
milk intake, increased weight gain, decreased starter intake, and decreased diarrhea in 
calves fed ad libitum milk compared with calves restricted to 10% of body-weight.  
Jasper and Weary (2002) compared conventional milk feeding practices (10% of body 
weight as-fed) with ad libitum diets in crossbred dairy calves and found that maximally 
fed calves consumed 89% more milk and gained 63% more weight than did 
conventionally-fed calves, but ate only 16% and 17% as much calf starter and hay, 
respectively, indicating that ad-libitum intake counters the goal of stimulating solid feed 
intake to promote rumen development, despite greater weight gain.  The study 
determined no detrimental effects of increased milk feeding on health during the pre-
weaning period and similar dry feed intake among calves after weaning. 
  More recently, data were generated regarding the effects of milk or milk replacer 
feeding rates on calf health.  Quigley et al (2006) fed calves 454 g/d of 20% CP / 20% fat 
milk replacer or greater daily intakes of 28% CP / 17% fat milk replacer.  Calves fed 
increased amounts of milk replacer had greater body weight gain, but upon exposure to 
coronavirus, morbidity was increased by 53% compared with controls.   Contrarily, 
calves in a study by Khan et al (2007) fed whole milk at a conventional rate of 10% of 
body weight had increased diarrhea during weeks 3 and 4 of age than did calves fed a 
greater volume of milk (20% of body weight), and Foote et al (2007) demonstrated 
decreased lymphocyte viability in calves fed for greater growth rates.  Conflicting reports 
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of effects of growth rate on health stimulated additional research about effects of growth 
rate on micronutrient deficiencies that affect immunity in calves.   Nonnecke et al (2010) 
demonstrated that increased growth rate increased the demand for vitamin E, but found 
other micronutrients not to be affected by growth rate.  Nonnecke et al (2014) further 
demonstrated increased demand for vitamins A, D3, and E during challenge with bovine 
viral diarrhea virus, and vitamin D3-deficient calves challenged with respiratory syncytial 
virus poorly expressed pro-inflammatory cytokines TNF-α, IL-1β, IL-6, IL-8, IL-12p40, 
and IFN-γ (Sacco et al 2012). Findings of increased micronutrient demand during 
increased growth and immune challenge led Krueger et al (2014) to explore the fat-
soluble vitamin status of calves fed PWM diets supportive of low or moderate growth 
when supplemented with vitamins A, D3, and E in excess of NRC recommendations.  
Calves consuming dietary milk without vitamin supplementation demonstrated vitamin 
D3 deficiency and increased utilization of vitamins A and E during inflammation 
associated with diarrhea.  Conclusions from these works reveal that PWM does not 
support the vitamin D3 and E requirements of calves when fed at a daily rate greater than 
10% of body weight.  Therefore, the micronutrient deficiencies created by increased 
growth in calves fed only PWM may increase susceptibility to infectious disease. 
Fat-Soluble Vitamins in Physiology 
  With vitamins A, D3, and E having been implicated in increased susceptibility to 
infectious disease, review of the roles of these micronutrients in physiology that pertain 
to immunity is warranted.  Vitamin E is best known as an antioxidant, whereas vitamins 
A and D3 modulate gene transcription.  Roles of all three vitamins are potentially 
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connected, as oxidation is an integral process of cytokine signaling for immune gene 
expression.   
As reviewed by Krueger et al (2014), the biologically active form of vitamin E is 
α-tocopherol, which has eight stereoisomers (Jensen et al, 2007).  RRR-α-tocopherol (d-
α-tocopherol) is the natural stereoisomer and has the highest bioavailability when 
supplemented to animals, although uptake of 2R- forms by tissues has been observed 
(Jensen et al, 2007).  Most synthetic supplements are a racemic mixture of the eight 
stereoisomers, denoted as all-rac-α-tocopherol, and include the less bioavailable SSS- and 
2S- forms.  Supplemental α-tocopherol is often bound as esters of acetate or succinate to 
increase stability but may be of non-ester form, especially when administered to neonates 
that lack pancreatic lipase for ester cleavage.  Bioactivity, distinguished from 
bioavailability by the “(measureable) effect on a clinical endpoint” (Jensen et al, 2007) 
has been established for both ester and non-ester forms of d-α- and all-rac-α-tocopherol 
by a series of rat resorption-gestation tests (Weiser and Vecchi, 1980; Weiser and Vecchi, 
1982).  The bioactivity of α-tocopherol stereoisomers is defined in international units 
such that 1 IU is equivalent to 1 mg of all-rac-α-tocopheryl acetate.  d-α-Tocopheryl 
acetate has a bioactivity of 1.36 IU, and d-α-tocopherol has a bioactivity of 1.49 IU 
(Voljč et al, 2011). 
The best-known role of α-tocopherol is that of antioxidant.  Post-absorptively, α-
tocopherol is selectively delivered from the chylomicron to α-tocopherol transfer protein, 
which facilitates incorporation into LDL for subsequent dispersal among cell 
phospholipids (Azzi et al, 2002).  Alpha-tocopherol scavenges reactive oxygen species by 
donating a hydrogen atom from the hydroxyl group located on the terminal aromatic ring, 
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thereby interrupting radical chain reactions (Engin, 2009; Sies and Murphy, 1991).  The 
subsequent tocopherol radical is positioned away from the membrane and toward the 
aqueous portion of the cell, which allows intra-cellular reduction by ascorbate (vitamin 
C), glutathione, and NADPH (Engin, 2009; Sies and Murphy, 1991).  The anti-oxidative 
role of α-tocopherol thus may spare both glutathione and NADPH, as these molecules 
would otherwise be consumed in radical chain reactions.   
Reactive oxygen species include superoxide (O2
-
) and peroxynitrite (ONOO
-
). 
Superoxide produced by monocytes and neutrophils reacts with nitric oxide to form 
peroxynitrite (Szabo et al, 2007).  Peroxynitrite induces cell dysfunction via direct 
initiation of membrane lipid peroxidation and nitration (Rubbo et al, 2009) and induces 
DNA damage and apoptosis via activation of the caspase cascade (Zhuang and Simon, 
2000).  Peroxynitrite also interacts with protein kinase C (PKC) to activate phospholipase 
A2, which causes secondary membrane lipid peroxidation and liberates the 
polyunsaturated fatty acid arachidonic acid (AA) from cell membrane phospholipids 
(Szabo et al, 2007; Rubbo et al, 2009; Traber and Atkinson, 2007; Chakraborti et al, 
2005; Church et al, 1993; Radi et al, 1991).  Free AA is oxidized by 5-lipoxygenase to 
pro-inflammatory leukotrienes (Rådmark and Samuelsson, 2010).  Rogue pro-
inflammatory signals increase expression of molecules such as acute phase proteins, 
which provide negative feedback to inflammation (Wang et al, 2001; Huntoon et al, 
2008) and thus decrease the magnitude of innate cell responses to their target stimuli.  
Indeed, vitamin E enhances superoxide production and intracellular killing by neutrophils 
and upregulates IL-1 and MHC class II antigen expression by macrophages in mature 
Holstein cows (Hogan et al, 1992; Politis et al, 1995).  Thus, vitamin E maintains the 
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integrity of immune signaling by protecting cells from immune oxidation and by 
preventing rogue pro-inflammatory stimuli.   
Whereas vitamin E affects immune signaling by quenching oxidation in the cell 
membranes, the dihydroxylated form of vitamin D3 is active as a steroid hormone.  As 
reviewed by Mora et al (2008), vitamin D3 is synthesized in the skin from 7-
dehydrocholesterol upon exposure to ultraviolent sunlight.  It is converted by hepatic 25-
hydroxylase to 25-(OH)-vitamin D3, which circulates systemically to the kidney where 
1α-hydroxylase generates 1,25-(OH)2-D3.  Concentration of this most active vitamin D3 
metabolite is regulated by 24-hydroxylase, which renders the compound inactive.  
Immune cells including monocytes and activated T and B lymphocytes express the 1α-
hydroxylase to generate increased local concentrations of the steroid. 
1,25-(OH)2-D3 complexes with the vitamin D receptor (VDR) and then dimerizes 
with retinoic X receptors in vitamin D response elements at promoter regions of sensitive 
genes (Mora et al, 2008).  The hallmark example of vitamin D3-stimulated gene 
expression is transcription of calcium binding protein in the intestinal epithelium 
(DeLuca and Schnoes, 1983).  In leukocytes, 1,25-(OH)2-D3 inhibits T and B lymphocyte 
proliferation and blocks IL-2 and IFN-γ to ultimately attenuate pro-inflammatory TH1 
responses (Mora et al, 2008).  VDR-mediated TH1 suppression thus may provide negative 
feedback to cell-mediated responses stimulated by inflammation and may partly regulate 
induction of class-switching for effective humoral memory responses.  Despite VDR-
mediated TH1 suppression and potential role in anti-inflammatory feedback, 1,25-(OH)2-
D3 seems to promote maturation of naïve T cells.  Sun et al (2010) demonstrated that T 
cell receptor signaling through the protein kinase 38 pathway induced VDR, and that 
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successive up-regulation of phospholipase C-γ1 (PLCγ1) was 1,25-(OH)2-D3 dependent.  
Increased PLCγ1 was correlated closely with T cell receptor sensitivity.  
Additional evidence supports 1,25-(OH)2-D3 enhancement of innate immunity.  
Transcription of the 1α-hyroxylase is stimulated by IFN-γ in monocytes (Mora et al, 
2008, Stoffels et al, 2006).  In monocytes, VDR mediates cathelicidin expression and 
enables in vitro cultures to better inhibit M. tuberculosis (Rook et al, 1986; Liu et al, 
2006).  Separately, 1,25-(OH)2-D3 upregulates other components of innate immunity, 
including CD14, cathelicidin antimicrobial peptide, and β-defensin 2 (White, 2008).  
Vitamin D3 paracrine and autocrine signaling is stimulated by inflammation associated 
with respiratory syncytial virus in pre-ruminant calves; increased expression of VDR, 1α-
hydroxylase, and 24-hydroxylase were associated with increased IFN-γ and other pro-
inflammatory cytokines in lesioned lung tissue (Sacco et al, 2012).  Vitamin D3 
deficiency, however, did not abrogate TH1 cytokine expression or VDR-mediated 
negative feedback through anti-inflammatory cytokines.   
From the multitude of studies examining vitamin D3 signaling in immunity, 
several concepts are clear.  VDR and 1α-hydroxylase are essential for immune autocrine 
and paracrine vitamin D3-mediated transcription, and both components are upregulated 
during immune stimulation.  Vitamin D3 signaling subsequently mutes TH1 responses and 
promotes TH2 activity.  The effects of vitamin D3 deficiency on VDR-mediated signaling 
are less clear, as are the divergent stimuli for VDR and hydroxylase up-regulation among 
immune cell lineages. 
Vitamin A metabolites are physiologically active in analogous fashion to those of 
vitamin D3.  As reviewed by von Lintig et al (2005), most naturally occurring vitamin A 
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is derived from carotenoids with provitamin A activity.  β-Carotene is the predominant 
naturally occurring carotenoid and is centrally cleaved by β,β-carotene-15,15’-oxygenase 
(BCO) into two retinal molecules.  Interconversion of retinal and retinol are facilitated by 
alcohol dehydrogenase and short-chain reductase; retinol is transported in serum by 
retinol-binding protein and taken up into cells by cellular-retinol binding protein for local 
conversion to active metabolites (Napoli, 1996).  Retinal is converted to retinoic acid by 
retinal dehydrogenase in a tightly regulated manner; retinoic acid is active as a gene 
transcription factor that complexes with retinoic acid receptor (RAR) and dimerizes with 
retinoid X receptors (RXR) on gene promoter regions (von Lintig et al, 2005; Napoli, 
1996).  9-Cis retinoic acid can also complex with the RXR homodimer to mediate 
transcription (Mora et al, 2008).  Vitamin A homeostasis is maintained at several 
regulated steps in metabolism.  Monomeric RXR can homodimerize or heterodimerize 
with peroxisome proliferator response element (PPAR) to induce BCO transcription (von 
Lintig et al, 2005).  BCO transcription is not induced by the RAR/RXR dimer.  Thus, 
retinoic acid saturation of its receptors initiates negative feedback on BCO to decrease 
conversion of carotenoids to retinal.  Cellular-retinol binding proteins (CRBP) also 
regulate retinoic acid generation (Napoli, 1996).  CRBP have high affinity for retinol and 
limit the concentration of intracellular retinol available for conversion to retinoic acid.  
Similarly, retinoic acid is chaperoned by cellular retinoic acid-binding protein.     
Contrary to 1,25-(OH)2-D3 signaling, retinoic acid enhances IL-2-induced T cell 
proliferation and cytotoxicity, thereby offering competition to the TH1 suppression of 
vitamin D3 (Ertesvag et al, 2002; Mora et al, 2008).   Agreeably, retinoic acid also inhibits 
B cell proliferation, although reports regarding effects on IL-6 and immunoglobulin 
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synthesis are conflicting (Blomhoff et al, 1992; Ballow et al, 1996).  IL-6 alters the 
context with which transforming growth factor (TGF)-β stimulates T cell differentiation; 
TGF-β and IL-6 co-stimulate pro-inflammatory TH17 cells, but TGF-β stimulates 
differentiation of naïve T cells to T regulatory cells (Treg) when IL-6 is not present.  
Perhaps not coincidentally, retinoic acid inhibits the IL-6 bias to favor Treg differentiation 
upon antigen presentation (Mucida et al, 2007).  This report is particularly interesting in 
neonatal immune development.  TGF-β is much more concentrated in bovine colostrum 
than in milk and has been speculated to affect mucosal immunity by facilitating IgA 
transport (Pakkanen and Aalto, 1997).  TH1 suppression in the neonate lends to 
speculation that retinoic acid and TGF-β participate together in the differentiation of 
mucosal Treg cells. 
Collectively, vitamins A, D3, and E are essential for maintaining the integrity of 
immune responses in young calves.  Although vitamin E functions differently than do 
vitamins A and D3, deficiencies in any of the fat-soluble vitamins could lead to 
abrogation or misinterpretation of antigen presentation and cytokine signaling.  Potential, 
aberrant effector and memory responses subsequently have a greater impact on future 
regulation and response to antigenic encounters. 
Microbial Colonization in the Neonate 
  The immunological state of the neonatal calf and nutritional contributions from 
colostrum and milk likely affect how commensalism is established at the intestinal 
epithelial barrier.  The lactocrine hypothesis published by Bartol et al (2008) posits that 
compounds in colostrum and milk are an extension of maternal influence on fetal 
development into early post-natal life.  Indeed, effects of colostrum and milk-borne 
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hormones on development of neonatal organs have been demonstrated, especially in 
reproductive and intestinal tissues.  Relaxin is produced by uterine and cervical tissues 
and is present in colostrum and milk, is passively transferred to the neonate, and exerts 
trophic effects on neonatal uterine and cervical tissues by 2 d post-parturition (Bartol et 
al, 2008; Goldsmith et al, 1994).  Similarly, insulin-like growth factors (IGF-1 and IGF-
2) are abundant in colostrum; each is concentrated at around 200 µg/L (Pakkanen and 
Aalto, 1997).  Neonatal bovine intestinal epithelial cells express receptors for both 
growth factors, and colostrum stimulates growth of the small intestine in neonatal piglets 
and calves (Pakkanen and Aalto, 1997).  Similarly, the intestinal microbiota has been 
described as a “virtual organ” (O’Hara and Shanahan, 2006) that participates in immune 
stimulation (O’Hara and Shanahan, 2006), metabolism (Nicholson et al, 2012), and 
neural regulation (Collins et al, 2012).   The lactocrine mechanisms for stimulation of 
neonatal systems are apparent through colostral immune components and growth factors; 
thus, extension of the lactocrine hypothesis to co-stimulation of these systems through 
pro- and prebiotic effects is logical. 
  Perhaps the most developed hypothesis of colostrum-mediated microbial 
interaction is that of IgG1-mediated microbial opsonization, as already discussed.  
Because IgG1 derives from circulating B lymphocytes, IgG1 titers in colostrum match 
antigens which the dam has previously encountered and which are thus at increased risk 
for encounter in the neonate.  Calves fed colostrum certainly do exhibit robust innate 
immune responses indicative of microbial encounter shortly after birth.  Krueger et al 
(2014) identified a five-fold increase in serum amyloid A within the first week of life that 
did not coincide with clinical illness and that persisted only until 2-3 weeks of age.  The 
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neonatal immune bias favors opsonization, antigen presentation, and Treg responses in an 
anti-inflammatory context (Sordillo et al, 1997).  Furthermore, continuous immune 
encounter of established microbes by lymphoid dendritic cells induces tolerant Treg 
responses hallmarked by IL-10 (Kelly et al, 2005).  Thus, instead of pro-inflammatory, 
neutralizing responses, the passive immunity acquired by the neonate perhaps fosters 
microbial colonization of the intestinal epithelium until a quorum for sustainable 
commensalism is attained. 
  Whereas the lactocrine effects of colostrum epitomize immune manipulation for 
establishment of commensalism, oligosaccharides in colostrum and milk are important 
prebiotic nutrients that also shape development of microbial communities.  As reviewed 
by Zivkovic and Barile (2011), bovine milk oligosaccharides (BMO) abound in 
colostrum and early lactation milk and exhibit prebiotic functions.  Both acidic and 
neutral BMO have been described in detail by using mass spectrometry (Zivkovic and 
Barile, 2011; Park and Lebrilla, 2005).  Milk oligosaccharides are largely built of 
repeating lactosamine residues and are distinguished as neutral or acidic by inclusion of 
fucose or sialic acid, respectively.  BMO can include additional residues of N-
acetylglucosamine, N-acetylhexosamine, N-acetylneuraminic acid, and galactose.  The 
large number of possible structures has led to a diverse characterization of BMO; 24 
acidic and 16 neutral BMO have been characterized in colostrum.      
  Neutral and acidic BMO function independently as prebiotic nutrients.  
Bifidobacteria extensively utilize neutral BMO as metabolic substrates; B. infantis grown 
on milk oligosaccharides interacted with Caco-2 cells in culture to increase expression of 
junctional adhesion molecule and induce IL-10 (Chichlowski et al, 2012).  However, 
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even within genus Bifidobacteria, related species show different preferences for neutral 
BMO as substrates.  B. infantis metabolizes both short and long chain BMO, whereas B. 
breve and B. longum bv. longum show less diversity in metabolic capabilities (Zivkovic 
and Barile, 2011).  Alternatively, acidic BMO contain carbohydrate residues within their 
structures that are homologous to glycans expressed by the intestinal epithelium.  Such 
residues are thought
 
to inhibit binding of enteric pathogens to epithelial glycan ligands 
(Zivkovic and Barile, 2011; Newburg, 2009).  Thus, BMO secretion in milk and 
colostrum may be a mechanism by which the dam confers innate protection to the 
neonate from pathogens and fosters increased numbers of mutualist or commensal 
organisms.  
  Protection by BMO may be essential to the integrity of the developing intestinal 
epithelium.  At parturition, the intestinal epithelium is composed of fetal enterocytes that 
retain the capacity for pinocytosis (Jochims et al, 1994).  Total tract epithelial turnover 
observed in the neonatal calf provides evidence that fetal enterocytes are sloughed from 
the intestine within 1-2 d after birth (Creamer and Bamforth, 1961).  Although the trophic 
effects of colostrum on the intestinal epithelium have not been specifically assigned to 
colostral growth factors, calves fed colostrum exhibit enhanced survival of mature 
intestinal epithelial cells compared with colostrum-deprived calves (Blättler et al, 2001).  
Colostrum deprivation thus potentiates an opportunistic niche in which fetal enterocytes 
slough from the epithelium without adequate regeneration of mature enterocytes to 
maintain epithelial barrier integrity.  Acidic BMO in dietary milk may especially protect 
the colostrum-deprived calf during barrier susceptibility while neutral BMO concurrently 
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foster the survival of mutualist organisms, such as Bifidobacteria, that stimulate 
regenerated epithelial cells for increased barrier effectiveness. 
  Colostrum and early lactation milk contain a multitude of non-nutritive 
compounds other than the immune and prebiotic components discussed so far that include 
lysozyme, lactoperoxidase, insulin, and other growth factors (Pakkanen and Aalto, 1997).  
Colostrum also contains cytokines that include TNF-α, IL-1β, IL-6, IL-1ra, and IFN-γ 
(Chase et al, 2008; Hagiwara et al, 2000).  Stimulatory effects to specific systems have 
not yet been assigned to each compound individually.  Collectively, however, the effects 
of the compounds that have been studied are consistent with the effects of feeding whole 
colostrum, which are generally to foster the healthy maturation of affected tissues.  
Consistently, colostral components regulate microorganisms and spare immature tissues 
from interactions that could result in hyper-responsiveness.  Also consistent is the 
observation that colostral compounds are secreted into milk for only several days after 
parturition (Stelwagen et al, 2009; Zivkovic and Barile, 2011).  Therefore, within days 
postpartum, the newborn calf must endogenously regulate its intestinal ecosystem to 
maintain health and the development of mutualistic microbial relationships. 
  Regardless of the immune or nutritional state during the perinatal period, the 
newborn calf is overwhelmingly exposed to microorganisms immediately upon 
parturition.  Domiguez-Bello et al (2010) documented different intestinal microbial 
conlonization of the intestine in human infants born via caesarian section or vaginal birth.  
The maternal vaginal canal is indeed colonized by organisms that become enteric 
residents in the neonate.  Organisms of phyla Bacteroidetes and Firmicutes primarily 
inhabit the vaginal canal, and genera Lactobacilli and Faecalibacteria, which belong to 
23 
 
 
the vaginal phyla, as well as Bifidobacteria and Prevotella, abundantly inhabit the 
neonatal intestine in several species (Dominguez-Bello et al, 2010; Wang et al, 2013; 
Taschuk and Griebel, 2012).   Such direct vertical transmission of commensal organisms 
suggests maternal influence.  The vaginal microbiome of adult human females is altered 
during late stage pregnancy and indicates yet another under-recognized mechanism of 
passive transfer for immunity (Romero et al, 2014).  Whether vaginal alteration of 
microbiota occurs across species is unknown, but the conserved pattern of hormonal 
regulation across species suggests that this is the case. 
  The newly resident microorganisms of the neonatal gastrointestinal tract interact 
with mucosal tissue shortly after birth.  Organisms that are the first to colonize the 
mucosa find a previously unoccupied niche that is thus shaped only by fetal development.  
The perinatal mucosal niche is well characterized and includes the complete, but naïve, 
repertoire of immune components (Taschuk and Griebel, 2012).  The epithelial brush 
border is present and expresses prebiotic glycoproteins that form the mucus layer 
(Buisine et al 1998).  However, the mucosa is in a pre-inflamed state at the time of 
parturition (Krueger et al, 2014), epithelial cell turnover is increased (Creamer and 
Bamforth, 1961), and immune responses are TH2 biased (Chase et al, 2008, Elenkov, 
2004).  Therefore, organisms that are among the first to colonize the tract arrive largely 
unimpeded by immune or microbial resistance and find free access to prebiotic nutrients 
that include sloughed cellular debris and extracellular glycoproteins, although the risk of 
stimulating inflammation is high.  The organisms that persist in the mucosa amid 
subsequent immune responses provide the first definition of the mucosal niche within the 
neonate. 
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  Lactobacilli and Bifidobacteria are two prevalent taxa in the mucosa of the pre-
weaned neonate (Dominguez-Bello et al, 2010; Wang et al, 2013; Taschuk and Griebel, 
2012).  Persistence of these organisms in the niche despite passive and endogenous 
immune activity and a vast number of microbial competitors indicates that their presence 
is highly stable and host-adapted (Walter et al, 2011).  The consistency with which these 
enteric species dominate in the mucosa may not simply be the outcome of a host-derived 
model; contrarily, organisms of both Lactobacillus and Bifidobacterium genera exert 
benefits to their host that may influence survival.  Lactobacilli favorably affect mucosal 
epithelial tight junction protein integrity and Bifidobacteria decrease both intestinal 
permeability and inflammation (Taschuk and Griebel, 2012).  Early survival via 
manipulation of host health may contribute to the establishment of a quorum for 
sustainable commensalism among compatible organisms and could shape a functional 
core microbiota.   
  One likely characteristic for compatibility among early colonizers is bacteriocin 
expression, reviewed by O’Shea et al (2012).  Bacteriocins are bacterial peptide exudates 
that inhibit the survival of other microorganisms and are classified in several groups.  
Gram negative species secrete microcins and colicins, but colicins are usually released 
only during apoptosis.  Generally, microcins and colicins affect transcription and 
translation in targeted organisms.  Gram positive phyla produce class I and II peptides 
that are diverse in structure and function.  Collectively, gram-positive bacteriocins disrupt 
cell wall formation and permeate cell membranes.  Nisin (class Ia) and reuterin (class IIc) 
are two bacteriocins with potent broad-spectrum activity, but most others are effective 
only on a narrow range of organisms (O’Shea et al, 2012; Talarico et al, 1989).  As noted 
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by O’Shea et al (2012), genetically distinct strains of bacteriocin-producing isolates from 
the same micro-environment frequently produce like bacteriocins.  Thus, microbes first 
colonizing the neonatal mucosa potentially affect the niche by producing compatible 
metabolites that affect the survivability of later-arriving strains.   
  Just as early-colonizing microbial species contribute to the definition of the 
mucosal niche, the pre-defined characteristics of the micro-ecosystem likely select for 
early symbionts.  Lactobacillus reuteri has divergently adapted to species-specific hosts 
through vertical transmission from dam to offspring over generations (Walter et al, 2011; 
Oh et al, 2009).  The unique, adaptive strategy of L. reuteri to its host has allowed the 
organism to persist despite the metabolic, immune, and microbial competition that is 
innate to any mucosal environment.  Thus, adaptation to co-existence of neonatal and 
microbial systems in close proximity is bi-directional; the functional core microbiota in 
an individual may be extensively shaped by early tract colonizers, but offspring may be 
genetically predisposed to a core by stable relationships that have persisted between 
organisms and their hosts over time. 
  Thus, the neonatal transition period marks the onset of interactions between 
neonatal mucosal tissue and commensal organisms.  Evidence supports active maternal 
regulation of neonatal colonization via immune bias, probiotic manipulation, and 
lactocrine messaging.  Organisms that arrive in the mucosa according to chance after 
maternal manipulation contribute to community structure through exudates and 
metabolites and ultimately affect the niche to affect survival of later-arriving organisms.  
The events surrounding parturition thus form the basis for an exclusionary intestinal 
resident microbial community. 
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Neonatal Johne’s Disease Infection 
  Mycobacterium avium, subsp. paratuberculosis (MAP) is the causative agent of 
Johne’s disease, which is a common, chronic gastroenteritis in ruminants that is nearly 
always fatal (Harris and Barletta, 2001).  Even prior to advanced, clinical stages of 
Johne’s disease, during which the infected adult animal becomes malnourished, MAP 
causes significant production losses by decreasing milk yield and increasing cull rates 
(Wilson et al, 1993).  MAP has been estimated to cause monetary loss ranging from $40 
to $227 per inventoried cow in the United States, thus causing substantial loss to U.S. 
dairy producers (Harris and Barletta, 2001; Ott, 1997; Stabel, 1998). 
  Neonatal calves are highly susceptible to MAP infection by fecal-oral 
transmission because of contact with contaminated feces, colostrum, and milk during and 
after parturition (Behr and Collins, 2010).  Naturally infected “supershedder” cows may 
shed greater than 10,000,000 cfu MAP / g in feces (Behr and Collins, 2010), thus creating 
a reservoir for neonatal infection.  Heavy shedders are readily identified by fecal culture 
when >50 cfu are present on solid agar culture medium (Stabel, 1997; Behr and Collins, 
2010).   Newly infected calves are also reservoirs for horizontal transmission among 
cohorts, with peak shedding during the early subclinical period occurring within two 
months post-infection as shown in experimentally inoculated animals (Mortier et al, 
2014a).  Upon ingestion, MAP is endocytosed by M cells of ileal Peyer’s patches and 
discharged into lymphoid follicles, whereupon the organism is internalized by dendritic 
cells or macrophages for antigen presentation (Harris and Barletta, 2001; Lugton, 1999).  
MAP replicates intracellularly in the tolerant lymphoepithelial tissues by surviving within 
the phagosome (Harris and Barletta, 2001; Lugton, 1999).  TH1 activated phagocytes can 
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be effective in killing intracellular MAP, but mycobacterial species are resistant to 
phagolysosomal degradation by acidification and oxygen radicals (Harris and Barletta, 
2001). 
  During the subclinical stage of infection, immune responses to MAP are largely 
TH1 mediated and are hallmarked by IFN-γ signaling (Harris and Barletta, 2001; Behr 
and Collins, 2010).  IFN-γ primarily derives from CD4+ cells during MAP infection, but 
CD8
+ 
and γδ T cells also secrete the cytokine (Behr and Collins, 2010).  IFN-γ and other 
TH1 cytokines stimulate innate phagocytic cell activity, as previously discussed, that is 
key to controlling early infection, despite the evasive nature of the organism.  Maternal 
TH1 suppression of the neonate undoubtedly increases susceptibility to MAP, as antigen 
presentation without contextual IL-12 can generate effector and memory TH2 cells, thus 
extending the life of the pathogen.  Experimentally infected calves develop a humoral 
response within 3-5 wk of age, with older calves becoming sero-positive sooner after 
inoculation than calves challenged at 2 wk of age (Mortier et al, 2014b).  Importantly, 
advancement of humoral responses and disease progression is dependent on the inoculous 
dose (Mortier et al, 2014b; Sweeney, 1996).   
  As reviewed (Behr and Collins, 2010), TH2-mediated humoral responses are 
characteristic of the transition to advanced Johne’s disease, during which IL-4 and IL-10 
dominate cytokine signaling and granulomatous lesions form around unresolved 
infections.  Treg cells secreting IL-10 and TGF-β mediate suppression of TH1 immunity 
during advanced disease.  Infected animals also exhibit increased numbers of B 
lymphocytes that may further suppress TH1 immunity.  γδ T cells may further contribute 
to development of granulomatous lesions in the intestinal mucosa that become infiltrated 
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with lymphocytes, macrophages, and giant cells.  Disruption of intestinal mucosal 
architechture leads to abrogated nutrient absorption and fatal malnourishment.   
  Prevention of transmission to the neonate has been identified as a critical 
opportunity for disease prevention and control.  Raw colostrum is recognized as a 
primary source of MAP infection for neonatal calves (Streeter et al, 1995).  A study with 
36 adult cows identified as subclinically infected by detection of MAP in feces 
demonstrated that 22% of these cows also shed MAP into colostrum (Streeter et al, 
1995).  More recently, both subclinically and clinically infected cows in early lactation 
were found to shed MAP into milk and colostrum, suggesting that even cows in the latent 
stage of infection may be perpetrating the spread of infection within a herd (Stabel et al, 
2014).  Thus, feeding colostrum to the newborn calf presents an inherent risk of pathogen 
transmission.  
  Batch pasteurization has proven to be an effective method of eliminating MAP 
from colostrum and milk and remains to be the most widely employed preventative 
method on commercial farms (Stabel, 2008).  Although preventing transmission through 
milk and colostrum is effective, minimizing contact with contaminated maternal feces is 
not always possible, so the need for additional, effective, preventative measures remains. 
  A heat-killed vaccine against MAP has been developed for commercial use in the 
United States (Stabel et al, 2011; Patton, 2011; Faisal et al, 2013; Tewari et al, 2014).  
The vaccine reduces fecal shedding of MAP and slows onset of disease but is not 
completely protective against disease progression (Tewari et al, 2014).  Consistent with 
observations of disease progression, the vaccine delays disease advancement by 
stimulating TH1 immunity (Faisal et al, 2013).  Seroconversion occurs at around 4-5 mo 
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post-inoculation and acquired immunity was reported to not interfere with diagnosis of 
M. bovis (Tewari et al, 2014; Stabel et al, 2011).  Stimulation of TH1 immunity has 
previously been recognized as an effective vaccine mechanism in young calves (Chase et 
al, 2008), but effects of abrogation of the neonatal TH2-bias on broader immune 
development and subsequent interaction with commensal microbiota remain less 
explored. 
   Interactions between MAP and other intestinal commensal organisms have been 
recently explored in two related studies (Karunasena et al, 2013; Karunasena et al, 2014).  
Mice fed Lactobacillus animalis exhibited decreased chronic inflammation, IFN-γ, and 
IL-6, but increased TNF-α and IL-17, during 180 d MAP infection compared with 
controls (Karunasena et al, 2013).  Chronic MAP infection was associated with decreased 
Roseburia and increased Desulfonema species, a shift which is more broadly associated 
with diseased states in cattle (Karunasena et al, 2014).  A greater focus has been placed 
on assigning causality of Crohn’s disease to MAP, but work in this area has so far been 
unsuccessful.  As summarized in a recent review of inflammatory bowel disease (IBD) in 
humans (Bosca-Watts et al, 2015), MAP has been isolated from IBD patients in a state of 
intestinal microbial dysbiosis, characterized by decreased Bifidobacteria, Lactobacilli, 
and Firmicutes. Correlation of MAP with broader intestinal dysbiosis is perhaps the best 
available explanation of a community dynamic involving the organism in question; a 
MAP exudate impairs the in-vitro phagolytic ability of macrophages and thus could act as 
an “indirect pathogen” (Friswell et al, 2010).  Much is yet unknown about how MAP 
might affect the immune-microbial relationships of the intestinal mucosa. 
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Conclusions 
  The neonatal calf is born immunosuppressed to accomodate vast microbial 
bombardment of epithelial barrier tissues at birth.  The immunosuppression takes the 
form of a TH2 bias that is stimulated by glucocorticoids of fetal and maternal origin.  
Antigen recognition by the neonate progresses through cytokine signaling that stimulates 
B lymphocyte differentiation and antibody production according to TH2 cytokines, but 
humoral responses are largely blunted.  Bioactive compounds in colostrum complement 
the immune state of the neonate; passively transferred IgG1 and leukocytes function 
under the TH2 bias to initiate Treg responses that might not be developed in an otherwise 
TH1 context, and innate components confer protection while pre-inflamed tissues are not 
yet saturated with endogenous innate components.  Despite increased susceptibility to 
pathogens such as MAP, the TH2 bias is an essential part of early post-natal development, 
but requires colostrum to effectively promote health.   
  Post-natal nutrition subsequently offers the metabolic substrates for endogenous 
growth and development, microbial development, and immune regulation.  Increased 
growth and metabolism can disrupt the integrity of immune signaling by inducing 
micronutrient deficiencies, which certainly shape host interactions in the mucosal niche.  
The integrity of interplay between neonatal and microbial systems over generations has 
led to stable commensal relationships that foster neonatal health and survival.  Despite 
species-specific predispositions for colonization, the maternal, nutritional, and 
endogenous influences that govern parturition ultimately affect the performance of the 
neonate.  
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CHAPTER 2 
EFFECTS OF COLOSTRUM AND VITAMINS A, D, AND E ON 
HAPTOGLOBIN AND CLINICAL HEALTH IN NEONATAL HOLSTEIN 
CALVES  
 
 
Abstract 
Thirty Holstein calves were obtained from two dairy farms in central Iowa at birth 
and randomly assigned to one of six treatment groups: 1) colostrum deprived (CD), no 
vitamins; 2) colostrum replacer (CR), no vitamins; 3) CR, vitamin A; 4) CR, vitamin D3; 
5) CR, vitamin E; 6) CR, vitamins A, D3, E, with 5 calves per treatment in a 14 d study.  
Calves were fed pasteurized whole milk (CD calves) or fractionated colostrum replacer 
(CR) at birth and injected with vitamins according to treatment group.  Thereafter, all 
calves were fed pasteurized whole milk (PWM) and supplemented orally with vitamins as 
assigned.  Calves fed CR acquired IgG1 and haptoglobin in serum within 24 of birth, 
whereas CD calves did not, and CR-fed calves were 2.5 times less likely to develop 
scours.  Additionally, synergistic effects of supplemental vitamins A, D3, and E on 25-
(OH)-vitamin D in serum at d 7 and a decreased incidence of scours in calves 
supplemented with vitamins D3 and E were observed.  Vitamin D3 deficiency was found 
in non-supplemented calves fed a basal diet of pasteurized whole milk.  Our results 
indicate (1) passive transfer of haptoglobin to neonatal calves, and (2) health benefits of 
supplemental vitamins D3 and E to calves fed pasteurized whole milk. 
Introduction 
Pasteurized whole milk (PWM) is a common component in calf diets on 
commercial dairy farms in the United States as producers seek to capture losses from 
waste milk.  Recent literature, however, has suggested that PWM alone does not meet the 
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vitamin A, D3, and E nutritional requirements of young calves and that these 
requirements are increased by increased growth rates and immune challenge (Krueger et 
al, 2014; Nonnecke et al, 2014).  Vitamin A and D3 metabolites target nuclear receptors 
to affect cell differentiation, tissue development, and immune cell signaling to promote 
epithelial tissue integrity and immune responses (Nelson et al, 2012;
 
Rhinn and Dollé, 
2012; Hall et al, 2011).  Vitamin E is an antioxidant that primarily protects cell 
membrane unsaturated fatty acids from oxidative processes such as respiration and 
inflammation (Traber and Atkinson, 2007).  PWM is deficient in vitamins D3 and E; 
PWM contains approximately 38.4 and 1.8 I.U./L of vitamins D3 and E, respectively, but 
recommended daily allowances for neonatal calves are 582 and 26.5 I.U., respectively 
(Krueger et al, 2014; NRC 2001).  PWM may satisfy the nutritional requirement for 
vitamin A in healthy, milk-fed calves, but animals experiencing inflammation have 
exhibited decreased serum retinol and retinol binding protein (Krueger et al, 2014; 
Rosales et al, 1996).  Thus, supplemental vitamins A, D3, and E may benefit the neonatal 
calf.  Commercial milk replacers often include vitamins in concentrations above those 
recommended by NRC; a recent technical bulletin recommended daily fortification of 
PWM with 20,000, 7,500, and 100 I.U. of vitamins A, D3, and E, respectively, for 
neonatal calf diets (Wood, 2013). 
Despite possessing a mature innate immune system at birth, newborn calves 
require stimulation of adaptive immunity and are highly susceptible to infection at 
epithelial barriers in the lungs and intestine.  Feeding calves colostrum within the first 24 
h of life is accepted widely as an effective means of delivering passive protection in a 
dose-dependent manner (Robison et al, 1988).  Maternal colostrum contains IgG1 
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antibodies, leukocytes, complement, and cytokines that confer passive immunity (Chase 
et al, 2008).  Leukocytes are degraded during the pasteurization and freezing processes 
that are recommended for commercial handling of colostrum; thus, in practice, immune 
stimulatory benefits are attributed to compounds in the whey fraction.  Fractionated 
colostrum replacer, used in this study, is concentrated colostral whey that contains IgG1 
and the many other non-nutritive, bioactive compounds of maternal colostrum that 
remain largely uncharacterized.  As passive, humoral immunity wanes during the post-
natal period, endogenous immunity is stimulated under a hormonally induced TH2 bias 
while TH2 immunity remains muted
 
(Chase et al, 2008).  
Cell-mediated TH1 responses are an important part of controlling subclinical 
infection of Mycobacterium avium subsp. paratuberculosis (MAP) in adult bovine 
animals (Stabel, 2010).  Infection rates of this pathogen are greatest during the neonatal 
stage when fecal-oral transmission risk is high.  Although infection as a neonate is not 
known to cause acute distress, the organism can survive and replicate in the host during a 
long subclinical latency before immune recognition (Stabel, 2010).  This study was thus 
conducted to assess the hypothesis that colostrum and supplemental vitamins A, D3, and 
E affect innate immunity of calves fed PWM and challenged with MAP by using serum 
acute phase proteins haptoglobin (Hp) and serum amyloid A (SAA) as evidence of acute 
inflammation.   
Materials and Methods 
Animals and treatments   
Thirty Holstein calves were obtained from two dairy farms in central Iowa at birth 
and randomly assigned to one of six treatment groups: 1) colostrum deprived (CD), no 
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vitamins; 2) colostrum replacer (CR), no vitamins; 3) colostrum replacer, vitamin A (CR-
A); 4) colostrum replacer, vitamin D (CR-D); 5) colostrum replacer, vitamin E (CR-E); 
6) colostrum replacer, vitamins A, D, E (CR-ADE), with 5 calves per treatment in a 14 d 
study.  All calves received a first feeding of colostrum replacer or pasteurized whole milk 
(PWM) within 3 h of birth; the CD calves were fed 1.9 L of PWM (40°C, Iowa State 
University Dairy Farm, Ames, IA 50014) as a control, whereas calves in the remaining 
five treatment groups received 375 g of fractionated colostrum replacer (Milk Products, 
Chilton, WI 53014) reconstituted in 1.9 L water at approximately 40°C.  The colostrum 
replacer contained 150 g bovine globulin protein concentrated from colostral whey.  
Calves received their respective vitamin or control treatments at the time of first 
feeding and throughout the study.  Calves in the CD and CR control groups were injected 
with 3 mL of placebo carrier solution (proprietary formulation, Stuart Products, Inc., 
Bedford TX). All vitamin solutions (Stuart Products, Inc.) were prepared in carrier 
solution.  Injectable solutions, which were administered at birth, contained 50,000, 
50,000, and 500 IU of retinyl palmitate, cholecalciferol, and d-α-tocopherol per mL, 
respectively.  Orally administered solutions, which were delivered daily in dietary milk, 
contained 25,000, 5,000, and 500 IU of the respective compounds. Calves in vitamin 
treatment groups were administered 3 mL injections subcutaneously at birth to deliver 
150,000 IU of retinyl palmitate (CR-A), 150,000 IU of cholecalciferol (CR-D), and 1,500 
I.U. of d-α-tocopherol (CR-E).  The CR-ADE calves received an injection containing all 
three compounds in the concentrations described. 
All calves were transported within 12 h of birth to the National Animal Disease 
Center, (NADC, Ames, IA 50010).  Calves were examined by a veterinarian before 
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transportation from each source.  Calves were housed indoors in individual hutches 
elevated from a concrete floor.  Ambient temperature was held at approximately 20°C.  
Upon arrival, calves were placed on a twice-daily feeding schedule with 12 h intervals at 
approximate feeding times of 06:00 h and 18:00 h.  At each feeding, calves were fed 2.7 
L of PWM that was transported from the Iowa State University Dairy Farm daily.  A 50 
mL sample of dietary milk from each feeding was retained.  All calves were offered milk 
via bottle and nipple, but refusals of greater than 0.1 L were administered to the calf via 
esophageal tube.  Calves received 1 mL of oral vitamin solution via dietary milk at each 
evening feeding, according to treatment group.  The first morning feeding in the study 
location marked d 1 of the study.  All calves were inoculated twice via dietary milk with 
10
8
 cfu per dose of Mycobacterium avium subsp. paratuberculosis (MAP), strain 167 
(clinical isolate), as previously described (Stabel et al, 2013) during the morning feedings 
of d 1 and d 3.  Calves were fed according to schedule for 13 d + 1 and were euthanized 
on d 14 + 1 for tissue harvest.  All animal procedures were approved by the Animal Care 
and Use Committee, National Animal Disease Center, Ames, IA.   
Health scoring and sample collection   
Calves were evaluated by investigators for five criteria that indicated general 
health status, including rectal temperature, cough, nasal discharge, fecal consistency, and 
attitude upon arrival and at each feeding thereafter.  Data generated from rectal 
temperature, fecal consistency score, and attitude score were analyzed statistically.  Fecal 
consistency and attitude scores were assigned on a scale of 0 to 3.  For fecal consistency, 
a score of 0 indicated a normal and solid consistency, a score of 1 was equivalent to semi-
formed and pasty feces, a score of 2 was equivalent to loose feces, and a score of 3 was 
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equivalent to watery feces and severe, debilitating scours.  For attitude, a score of 0 was 
used to record a bright-eyed and alert calf, a score of 1 was used to record minor ocular 
discharge or an ear flick, a score of 2 was used to record moderate ocular discharge or 
unilateral ear droop, and a score of 3 was used to record heavy ocular discharge, bilateral 
ear droop, or general unresponsiveness. 
Whole blood was collected via jugular venipuncture from all animals on d 0 
within four hours of birth and prior to vitamin injection.  Because calves originated from 
multiple sources, some calves received the first feeding of colostrum replacer several 
hours before blood collection.  Blood was collected from all animals again on d 1 at 12 to 
24 h post-partum, on d 7, and on d 14 prior to morning milk feeding and after a 12 h fast.  
At each time point, 20 mL of blood was collected into vacutainer tubes (Becton, 
Dickenson and Co., Franklin Lakes, NJ 07417) and serum was harvested and stored at -
20°C until analyses were performed.   
Serum vitamin analyses   
Retinol and α-tocopherol were quantified in serum and dietary milk by reverse 
phase high performance liquid chromatography (RP-HPLC) after extraction with hexane 
as described by Goff et al (2002).  Retinyl palmitate was additionally quantified in serum 
of CR, CR-A, and CR-ADE calves only, using procedures described by Stahr (1991).  
Total 25-(OH)-Vitamin D equivalents were quantified by radioimmunoassay after 
extraction of serum with acetonitrile.  Serum (50 µL) was added to 500 µL acetonitrile 
and mixed carefully.  Then, 25 µL of the extracted sample was combined with an equal 
volume of radioiodinated 25-(OH)-vitamin D (Diasorin) (10,000 cpm in 25 µL ethanol 
with 0.01 M sodium phosphate).  The samples were then centrifuged at 2000 x g for 10 
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min, and the pellet was discarded.  The radioimmunoassay then was conducted as 
described by Hollis et al (1993).   
Serum protein analyses   
Immunoglobulin G1 (IgG1) in sera was quantified by capture ELISA, as described 
by Nonnecke et al (2012).  Antibodies (#A10-116A, #A10-116P) and reference serum 
(RS10-103) for the assay were purchased from Bethyl Laboratories, Inc. (Montgomery, 
TX 77356), and colorimetric reagents (#52-00-00, #50-85-04) were purchased from 
Kirkegaard and Perry Laboratories, Inc. (Gaithersburg, Maryland 20878).  Sera were 
diluted 1:60,000 to achieve absorbance values within range of the standard curve.  
Haptoglobin was quantified by using a bovine-specific Hp ELISA (Immunology 
Consultants Laboratory, Inc., Newberg OR) according to manufacturer’s instructions.  
Serum samples were diluted 1:50 in 1x diluent according to manufacturer’s instructions.  
Samples that resulted in absorbance values (450 nm for 0.1 s on a Victor X3 2030 
multilabel reader, Perkin Elmer, Waltham, MA 02451) that fell outside of the standard 
curve were diluted 1:5,000 or 1:10,000 to achieve absorbance values within range.  
Serum amyloid A (SAA) was quantified by using the PHASE
TM
 RANGE Multispecies 
SAA ELISA kit (Tridelta Development Ltd., Maynooth Co. Kildare, Ireland) according 
to manufacturer’s instructions.  Sera were diluted 1:5,000 to achieve absorbance values 
within range of the standard curve.  Absorbance was determined for each sample as 
described for serum Hp. 
Colostrum and dietary milk analyses  
Haptoglobin, SAA, and IgG1 were quantified in colostrum by using ELISA 
procedures as already described.  For IgG1 quantification, colostrum replacer was 
49 
 
 
reconstituted as described, and then dilutions were prepared at 1:25,000, 1:100,000, 
1:200,000, 1:400,000, 1:800,000, and 1:1,600,000.  For Hp and SAA quantification, 
dilutions were prepared at 1:500, 1:1,000, 1:2,000, and 1:4000.  Retinol and α-tocopherol 
were quantified in six milk samples representative of the entire study period by using 
procedures already described. 
Statistical analyses 
Vitamin concentrations in serum were analyzed by repeated measures ANOVA 
by using mixed procedures of SAS (version 9.3, SAS Institute Inc., Cary, NC).  Calf 
served as the experimental unit.  The model included fixed effects of treatment and 
sample day; calf was included in the model as a random effect.  Contrast statements were 
used to separate least square means of supplemented and non-supplemented calves for 
each vitamin treatment.   
Serum acute phase proteins were analyzed within each day by using contrast 
statements in mixed procedures of SAS.  Contrast statements were used to separate least 
square means on the basis of colostrum and vitamin supplementation.  IgG1 in serum at d 
1 was analyzed similarly on the basis of colostrum supplementation only.  
Body temperature and dietary milk refusals were grouped into three time periods:  
D 1-4, D 5-9, and D 10-13.  Data were analyzed by repeated measures ANOVA by using 
mixed procedures of SAS.  Calf served as the experimental unit; the model included fixed 
effects of treatment and period and random effect of calf.  Contrast statements were used 
to separate least square means on the basis of colostrum and vitamin supplementation. 
Ordinal data for attitude and fecal scores were analyzed by using a multinomial 
regression via the GENMOD procedure of SAS.  Scores were ordered from least to 
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Figure 1: Serum IgG1 at d 1 post-partum.  Calves were either 
colostrum deprived or fed 375 g of fractionated colostral whey 
containing 150 g globulin protein reconstituted in 1.9 L water.  
IgG1, immunoglobulin G1; CD, colostrum deprived; CR, 
supplemented with colostrum replacer; A, supplemented with 
vitamin A; D, supplemented with vitamin D; E, supplemented 
with vitamin E; ADE, supplemented with vitamins A, D, and 
E.  *P<0.0001 for the contrast of CD against CR, CR-A, CR-
D, CR-E, CR-ADE. 
 
greatest, with lower scores representing improved attitude or fecal consistency.  The 
model included only the fixed effect of treatment.  Contrast statements were used to 
generate maximum likelihood and odds ratio estimates of the likelihood of a treatment 
resulting in lower attitude or fecal scores.  By default, maximum likelihood estimates 
were normalized to the performance of the CR-E group. 
Results 
Colostrum and dietary milk analyses 
Haptoglobin, SAA, and IgG1 were quantified in reconstituted colostrum replacer.  
The minimum determined concentration of IgG1 was 393.3 mg/mL, which is above the 
manufacturer’s guaranteed minimum of 375 g per dose (197.4 mg/mL).  Concentration of 
Hp was 46.8 ug/mL, but quantification of SAA in colostrum replacer was inconclusive.  
Retinol and α-tocopherol were quantified in dietary milk samples and averaged 31.2 ± 2.4 
and 4,996 ± 461 ng/mL, respectively.   
Serum IgG1 and vitamins 
To determine effects of 
colostrum replacer feeding on 
passive transfer of 
immunoglobulin to neonates, 
IgG1 was quantified in serum 
at d 1. Calves supplemented 
with colostrum at first feeding 
(all except CD) exhibited 
greater (P < 0.001) 
* 
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concentrations of IgG1 in serum by d 1 of age (Figure 1).  Treatment means ranged from 
4.07 to 5.94 mg/mL for calves receiving colostrum, but averaged only 0.11 ± 0.08 mg/ml 
for CD calves.  Concentration of IgG1 in serum at d 1 was not different among the five 
CR groups.   
Retinol, 25-(OH)-vitamin D, and α-tocopherol concentrations were measured in 
serum to quantify the effects of pharmacological vitamin supplementation.  Significance 
of main effects of treatment, day, and the treatment-by-day interaction in the ANOVA are 
stated in Table 1.  Calves supplemented with retinyl palmitate (CR-A and CR-ADE) 
exhibited greater (P < 0.05) overall concentrations of retinol in serum compared with 
non-supplemented calves (Figure 2a).  Retinol in serum did not differ between the CR-A 
and CR-ADE groups and averaged 279.0 ± 42.5 and 230.2 ± 39.9 ng/mL, respectively, on 
d 14.  Effect of day was evident as calves achieved greater concentrations of retinol in 
serum by d 14 than at birth; non-supplemented and supplemented calves achieved a 2.8  
and 3.0 fold increase, respectively, from d 1 to d 14. Although retinol was not affected by 
injection of retinyl palmitate at d 1, serum retinyl palmitate was significantly greater (P < 
0.001) than controls in CR-A and CR-ADE calves (Figure 2b), which averaged 1,012 ± 
198 and 1,152 ± 452 ng/mL, respectively.  Retinyl palmitate was not detected in CR 
calves and was negligible (< 10.0 ng/mL) in all calves at measured time points other than 
d 1.   
 
Table 1.  Significance of main effects in data analyzed by repeated measures ANOVA. 
 P-value
1 
Parameter Treatment Day Treatment*Day 
Retinol 0.02 <0.0001 0.46 
25-(OH)-Vitamin D <0.0001 <0.0001 <0.0001 
α-Tocopherol <0.0001 0.0005 0.003 
1 P-value associated with type 3 test of fixed effects in Proc Mixed of SAS (SAS Institute  Inc., Cary, NC). 
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Figure 2:  Retinol and retinyl palmitate in serum of calves. Calves were supplemented (CR-A, CR-ADE) 
or not supplemented (CD, CR, CR-D, CR-E) with retinyl palmitate via injection at birth and daily oral 
supplementation of 150,000 and 25,000 I.U., respectively.  A. Retinol in serum of calves at birth, d 1, d 7, 
and d 14 of age.  Means with different superscripts are different, P < 0.01. CD, CR, 
CR-A, CR-D, CR-E, CR-ADE.  B. Retinyl palmitate in serum of calves at d 
1.  *Different from CR control group, P < 0.001. 
 
A. 
B. 
a 
b 
* 
* 
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   Time after birth, day 
 
Figure 3:  25-(OH)-vitamin D equivalents in serum of calves at birth, d 1, d 7, and d 14 of age.  Calves 
were supplemented (CR-D, CR-ADE) or not supplemented (CD, CR, CR-A, CR-E) with 
cholecalciferol via injection at birth and daily oral supplementation of 150,000 and 5,000 I.U., 
respectively.  Means with different superscripts are different, P < 0.001.  CD, CR, 
CR-A, CR-D, CR-E, CR-ADE.   
 
           Time after birth, day 
 
Figure 4: α-Tocopherol in serum of calves at birth, d 1, d 7, and d 14 of age.  Calves were 
supplemented (CR-E, CR-ADE) or not supplemented (CD, CR, CR-A, CR-D) with d-α-tocopherol 
via injection at birth and daily oral supplementation of 1,500 and 500 I.U., respectively.  *Means of 
supplemented and non-supplemented groups are different, P < 0.001. CD, CR, 
CR-A, CR-D, CR-E, CR-ADE.   
 
c 
b 
a 
b 
a 
* 
* 
* 
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Supplementation of calves with cholecalciferol (CR-D and CR-ADE) resulted in 
greater (P < 0.001) overall concentration of 25-(OH)-vitamin D in serum when compared 
with non-supplemented calves (Figure 3).  No effect of the injection was seen at d 1, but 
by d 7 calves in both vitamin D3-supplemented groups had greater (P < 0.001) serum 25-
(OH)-vitamin D than non-supplemented calves.  Although the concentration of vitamin 
D3 was the same in CR-D and CR-ADE supplements, the CR-ADE calves had greater (P 
< 0.05) 25-(OH)-vitamin D in serum than did CR-D calves on d 7.  By d 14, CR-D and 
CR-ADE groups averaged 94.5 and 100.4 ng/mL, respectively.    Concentration of 25- 
 (OH)-vitamin D in serum of calves not supplemented with vitamin D3 declined below 
20.0 ng/mL by 14 d of age, which indicated vitamin D deficiency.   
As with vitamins A and D, calves supplemented with d-α-tocopherol (CR-E and 
CR-ADE) exhibited greater overall concentrations of α-tocopherol in serum (P < 0.001), 
but a response to supplementation was observed as early as d 1, reaching its highest point 
during the study (Figure 4). Thereafter, α-tocopherol concentrations in vitamin E- 
Table 2. Hp and SAA concentration in serum of Holstein calves, µg/mL
1
. 
  D 0
2 
D 1 D 7 D 14 
Treatment Mean SEM Mean
 
SEM Mean SEM Mean SEM 
Hp          
CD 2.9 0.2 **28.0
 
7.1 354.1 211.8 434.9 411.3 
CR 14.7 11.3 171.1 48.8 1074.9 420.3 539.0 530.6 
CR-A 40.8 30.5 200.6 41.2 475.1 453.2 73.5 71.0 
CR-D 14.4 6.9 141.8 55.4 522.9 341.2 140.3 134.7 
CR-E 12.9 4.9 125.1 28.4 1014.9 820.3 319.0 213.8 
CR-ADE 11.2 3.8 203.0 51.7 2,203.7 1,349.4 1,535.5 1,519.0 
SAA          
CD 24.8 59.0 *212.6
 
58.0 540.6
 
155.8 561.0 307.6 
CR 201.9 84.2 448.8
 
116.2 587.5
 
140.8 253.8 103.7 
CR-A 41.7 10.5 297.4
 
60.6 232.4
 
54.9 206.8 35.4 
CR-D 171.2 78.4 410.8
 
82.6 443.8 88.1 353.1 90.7 
CR-E 71.4 39.2 370.7
 
85.2 374.1
 
131.7 189.6 40.8 
CR-ADE 172.1 97.4 556.6
 
94.6 653.4
 
126.0 495.0 163.2 
*P < 0.05,  **P < 0.01;  denotes difference between CD and collective CR groups.   
1
Each day was analyzed individually.  SEM reported for each day.  Inter-day comparisons not valid. 
2
Some calves received colostrum several hours before blood collection on d 0. 
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Figure 5: Serum haptoglobin at d 1 post-partum.  
Calves were either colostrum-deprived or fed 375 g 
of fractionated colostral whey containing 150 g 
globulin protein reconstituted in 1.9 L water.  CD, 
colostrum-deprived; CR, supplemented with 
colostrum replacer; A, supplemented with vitamin A; 
D, supplemented with vitamin D3; E, supplemented 
with vitamin E; ADE, supplemented with vitamins 
A, D, and E.  *P<0.0001 for the comparison of CD 
and collective CR groups. 
 
supplemented calves approximated 2,800 ± 600 µg/mL, which was significantly greater 
(P < 0.001) than concentrations in non-supplemented groups.  α-Tocopherol in serum did 
not differ between CR-E and CR-ADE groups. 
Acute phase proteins 
Serum acute phase proteins 
Hp and SAA were quantified at d 0, 
1, 7, and 14 to elucidate effects of 
colostrum and vitamin 
supplementation on inflammatory 
responses of the neonate (Table 2).  
No effect of vitamin supplementation 
was observed for either protein, but at 
d 1, calves supplemented with 
colostrum replacer exhibited 
concentrations of serum Hp (Figure 5) 
and SAA that were 501% greater (P < 0.01) and 96% greater (P < 0.05), respectively, 
than in CD calves. 
Clinical health 
Calves were evaluated twice daily to obtain health data; body temperature and 
volume of refused dietary milk were recorded and calves were scored for attitude and 
fecal consistency.  Mean body temperature of calves throughout the study ranged from 
38.8°C for CR-E calves to 39.0°C for CR-ADE calves.  Means for these two treatment 
groups tended to be different (P < 0.1), but no other differences were detected.  Dietary  
* 
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Table 3.  Average milk refusal per feeding, L 
 Treatment 
Period CD CR CR-A CR-D CR-E CR-ADE SEM 
D 1-4 0.018 0.048 0.227 0.213 0.002 0.041 0.092 
D 5-9 0.429* 0.073 0.036 0.094 0.000 0.315 0.158 
D 10-13 0.131 0.000 0.224 0.352 0.264 0.266 0.206 
*Significant difference between CD and collective CR groups, P < 0.1. 
 
Table 4.  Maximum likelihood estimates
1
 of producing lower fecal consistency and attitude scores. 
Category CD CR CR-A CR-D CR-E
2 
CR-ADE 
Fecal Consistency -1.31 -0.82 -0.68 0.27 0.00 -0.65 
Attitude -1.03 1.30 -0.37 -0.61 0.00 -0.51 
1
Maximum likelihood estimate is stated as the probability of producing a lower ordinal score than CR-E 
calves. 
2
CR-E was the default group with which comparisons were made according to alphabetical order. 
 
milk refusals are stated in Table 3.  Colostrum-deprived calves refused greater volumes 
of milk (P < 0.1) than did CR-fed calves during d 5-9 of age.  Although not significantly 
different than other CR-fed calves, CR-E calves refused negligible volumes of dietary 
milk during the first two periods of the trial. 
 Throughout the study, CR-fed calves were 2.5 times more likely to produce solid 
feces than were CD calves (Table 4).  Among CR-fed calves, those supplemented 
individually with vitamins D and E were 2.2 (P < 0.01) and 1.6 (P < 0.05) times, 
respectively, more likely than others to produce solid feces.  The effect was not replicated 
in CR-ADE calves.  Similarly, CR-fed calves were 2.7 times less likely to exhibit signs of 
depression than were CD calves.  Among CR-fed calves, however, those supplemented 
with vitamin D were 2.4 times more likely to exhibit depression.  
Discussion 
This study reveals a previously unrecognized consequence of colostrum 
supplementation to dairy calves.  Our principal finding was that calves consuming 
acellular colostral whey exhibit increased concentrations of Hp in serum within 24 h of 
feeding.  The observed increase occurred prior to inoculation with MAP and, therefore, is 
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not a result of pathogenic challenge.  Hiss-Pesch et al (2011) demonstrated that both 
jejunal absorption of Hp and endogenous hepatic synthesis of the molecule occur within 
24 h post-partum in colostrum-fed piglets.  Although the present study does not fully 
demonstrate either mechanism in calves, our finding suggests redundancy across species.  
Haptoglobin synthesis is induced by IL-6 type cytokines
 
and is thought to attenuate the 
inflammatory response in a negative feedback loop.  Therefore, greater concentrations of 
Hp in serum indicate more severe inflammation, although this regulatory mechanism has 
not been directly demonstrated in neonatal calves (Wang et al, 2001; Huntoon et al, 
2008).  Huntoon et al (2008) demonstrated aberrant adaptive immune responses in Hp 
knockout mice, including stunted lymphocyte maturation, disruption of antigen 
presentation, and failure to mount effective antibody-mediated recall responses. The role 
of Hp in development of immunity in adult animals suggests that its presence in 
colostrum contributes to neonatal immune development as well.  The neonatal calf is 
born without immunoglobulin in a hormonally induced, tolerant state, but innate 
components of the immune system are complete and mature (Chase et al, 2008).  
Cytokines including TNF-α, IL-1β, IL-6, IL-1ra, and IFN-γ in colostrum promote 
immune system activity, especially monocyte and neutrophil migration to tissues and Th2 
biased adaptive responses (Chase et al, 2008; Hagiwara et al, 2000).  Mature B 
lymphocytes are scarce and respond weakly to TH2 signaling, such that endogenous 
antibody is insufficient to cope with antigenic stimuli
 
(Chase et al, 2008).  Thus, the TH2 
bias may contribute to establishment of microorganisms throughout the epithelial barrier 
tissues until a quorum for tolerogenic commensalism is reached.  The integral role of Hp 
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in antigen presentation and response may support the TH2 bias and subsequent immune 
education.  
The TH2 bias may partially account for the high infection rate of MAP during the 
neonatal period, as adult immune responses during the subclinical stage of infection are 
predominantly TH1 mediated (Stabel, 2010).  Prematurely breaking the TH2 bias through 
use of adjuvanted vaccines has proven effective in generating adaptive cell-mediated 
memory responses
 
(Chase et al, 2008), but may affect how the calf participates in 
establishment of commensalism.  Passively transferred maternal antibody, especially 
IgG1, corrects the agammaglobulinemic state and confers protective immunity, but does 
not break the TH2 bias (Chase et al, 2008; Robison et al, 1988).  In our study, CR-
supplemented calves demonstrated increases in both Hp and IgG1 within 24 h.  The 
colostrum-deprived calf, which lacks these molecules, may also lack the ability to sustain 
the TH2 bias and interact appropriately with microorganisms.   
Colostrum-deprived calves also exhibited a lower concentration of SAA at d 1 
than did CR calves, but SAA concentration at d 1 was appreciably greater than at d 0.  
Serum amyloid A was not conclusively quantified in colostrum replacer, but results 
suggest that the molecule was both transferred passively and synthesized endogenously.  
Krueger et al (2014)
 
previously identified increased SAA in calves through the first 3 wk 
of life that was independent of clinical health, but likely related to early recognition of 
microbial antigens.  Quantifiable SAA at d 1 of age in CD calves supports the hypothesis 
of endogenous SAA synthesis within the first 24 of life. 
Secondarily, this study explores the dynamics of pharmacological vitamin 
supplementation to the neonatal calf by injection and oral administration.  Injection with 
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d-α-tocopherol caused an obvious and immediate increase in serum α-tocopherol that was 
only partially sustained by the oral supplement after 7 d.  Contrarily, metabolites of 
injected vitamins A and D3 were increased only after sustained supplementation.  d-α-
Tocopherol is the most bioactive and bioavailable of the tocopherols (Jensen and 
Lauridsen, 2007), whereas retinyl palmitate requires cleavage of the ester to yield retinol 
and vitamin D3 is hydroxylated by hepatic 25-hydroxylase to yield 25-(OH)-D3 (Horst et 
al, 2005).  Therefore, the time required for metabolism of the injected vitamins A and D3 
to our measured metabolites may have exceeded the 12-24 h allotted before our first 
measurement in serum, whereas we measured the same vitamin E compound that was 
supplemented. 
After 7 d of sustained supplementation, we observed an apparent synergism of 
vitamins A, D3, and E supplementation on 25-(OH)-vitamin D concentrations.  Synergy 
of this nature is previously undescribed, although vitamin D3 has been shown to 
exacerbate the aberrations to bone and intestinal physiology caused by hypervitaminosis 
A, characterized as bovine hyena disease (Takaki et al, 1996).  Retinoic acid and 1,25-
(OH)-vitamin D3 are the bioactive forms of retinol and vitamin D3, respectively, and the 
nuclear receptors of these two compounds heterodimerize to cooperatively mediate gene 
expression (Schräder et al, 1993).  It is conceivable that increased retinoic acid via 
supplemental retinyl palmitate could inhibit the 1-hydroxylase to prevent conversion of 
25-(OH)-D3 to its di-hydroxylated form, thus accounting for the observed synergy.  
The oral vitamin supplementation in this study closely mimicked that published 
by Nonnecke et al
 
(2010); thus, we expected vitamin concentrations in serum to exceed 
values reported in that study (180, 65, and 2,500 ng/mL of retinol, 25-(OH)-vitamin D3, 
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and d-α-tocopherol, respectively, in serum by d 7) because of the additional injectable 
vitamin supplementation on d 0.  Values in supplemented calves at d 7 agreed with 
expectations, with the exception that 25-(OH)-vitamin D was increased beyond 
expectations in the CR-ADE group.  Additionally, α-tocopherol exceeded 6,000 ng/mL 
within 24 h before reverting to an expected value of greater than 2,500 ng/mL by d 7.  
Notably, serum retinol increased in both supplemented and non-supplemented 
calves from d 1 to d 14.  Retinol measured in milk was equivalent to less than 1 I.U., but 
contributions from carotenoids were not measured.  Nozière et al (2006)
 
reported that 
whole milk from cows fed silage may contain up to 0.215 µg vitamin A per mL, mostly 
from carotenoids.  Using this value, our calves may have received up to 1,278 I.U. of 
vitamin A from carotenoids daily in dietary PWM.  We observed no indication of vitamin 
A deficiency in non-supplemented calves.  Non-supplemented calves, however, did 
exhibit deficiencies in vitamins D3 and E.  Control calves failed to achieve 600 ng/mL α-
tocopherol, and control calves had less than 20 ng per mL 25-(OH)-vitamin D in serum 
by d 7.  Concentrations of 3,000 and 30 ng/mL, respectively, have been identified as 
epidemiologic requirements for good health in adult animals (Nelson et al, 2012; Weiss et 
al, 1997). 
Our results agree with previously reported concentrations of vitamins A, D, and E 
in non-supplemented neonatal calves fed PWM (Krueger et al, 2014).  Nonnecke et al 
(2014) additionally identified vitamin D and E utilization during bovine viral diarrhea 
virus infection in preruminant calves.  In the present study, vitamin D- and E-replete 
calves were least likely to exhibit scours from uncontrolled illness, but correction of D 
and E deficiencies did not alter expression of acute phase proteins at d 7 or 14.  CR-E 
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calves tended to have lower body temperatures throughout the study, but our result was 
inconclusive, and additional work is needed to evaluate vitamin E as an anti-pyretic 
agent.  The increased likelihood of depression in vitamin D3-supplemented calves is also 
notable but remains unexplained by classical vitamin D toxicity characterized by 
hypercalcemia; 6 calves in a study by Sacco et al (2012) achieved 177.3 ng/mL without 
significantly increased serum Ca
2+
 or body temperature, although 2 of the 6 calves 
exhibited acutely increased respiration rates and decreased feed intake. 
Conclusions 
Colostrum-deprived calves fail to acquire Hp and IgG1 within 24 h of birth. 
Additionally, supplementation of vitamins D3 and E to whole milk diets is needed to 
correct deficiencies of these nutrients, but co-supplementation of vitamins, A, D3, and E 
may synergistically increase 25-(OH)-vitamin D in serum.  Synergy was observed only at 
d 7 and warrants further exploration.  Correction of vitamin D and E deficiencies 
decreased incidence of scours from uncontrolled infection among colostrum-fed calves, 
but did not alter expression of inflammatory acute phase proteins.  PWM diets need to be 
fortified with vitamins D3 and E to correct nutritional deficiencies and improve health.  
Feeding colostrum to young calves not only provides passive humoral protection via 
IgG1, but provides immune regulatory molecules such as Hp that may shape endogenous 
immune development and interaction with commensal microorganisms. 
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CHAPTER 3 
 
PERIPHERAL BLOOD AND MESENTERIC LYMPH NODE MONONUCLEAR 
CELL RESPONSES TO MYCOBACTERIUM AVIUM, SUBSP. 
PARATUBERCULOSIS IN COLOSTRUM-DEPRIVED AND COLOSTRUM-
REPLETE HOLSTEIN CALVES SUPPLEMENTED WITH FAT-SOLUBLE 
VITAMINS 
 
Abstract 
 Peripheral blood and mesenteric lymph node mononuclear cells (PBMC and 
MNL, respectively) were obtained from 30 calves that were assigned randomly at birth to 
one of six treatment groups: 1) colostrum deprived (CD), no vitamins; 2) colostrum 
replacer (CR), no vitamins; 3) CR, vitamin A; 4) CR, vitamin D3; 5) CR, vitamin E; 6) 
CR, vitamins A, D3, E, with 5 calves per treatment in a 14 d study.  Calves were injected 
with appropriate vitamin supplements and fed pasteurized whole milk (CD calves) or 
fractionated colostrum replacer (CR) at birth.  Thereafter, all calves were fed pasteurized 
whole milk fortified with vitamins according to treatment.  Calves were orally inoculated 
with 10
8
 cfu of Mycobacterium avium subsp. paratuberculosis (MAP) on d 1 and 3 of 
age.   
PBMC and MNL were analyzed by flow cytometry as fresh cells, after 3 d culture 
with PHA, and after 6 d culture with a whole cell sonicate of MAP (MPS).  Peripheral γδ 
T cells constitutively expressed CD25 more abundantly than did other PBMC and were 
identified as a predominant lymphocyte subset, with a decreased percentage noted in CD 
calves. Stimulation of PBMC with PHA caused proliferation of CD4
+ 
and CD8
+
 subsets 
in a manner consistent with TH1 signaling, whereas the MNL response was dominated by 
IgM
+
 B cell proliferation in a TH2-like fashion.  PHA and MPS stimulation decreased the 
relative abundance of γδ T cells among PBMC, but MNL γδ T cells proliferated upon 
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stimulation with MPS.  These results identify γδ T cells as key early responders to 
intracellular infection in neonatal calves and suggest that colostrum may be an important 
mediator of this response.  
Introduction 
 Neonatal calves are susceptible at parturition to fecal-oral infection by 
Mycobacterium avium, subsp. paratuberculosis (MAP), an obligate intracellular 
pathogen and the causative agent of Johne’s disease.  MAP is shed in the feces of 
subclinically and clinically infected animals, as well as in colostrum and milk of animals 
in advanced stages of Johne’s disease (Harris and Barletta, 2001; Streeter et al, 1995); 
thus, reservoirs for infection are abundant to offspring of infected dams.  Maternal 
suppression of fetal TH1 immunity during late stage pregnancy persists into early post-
natal life and potentially compromises neonatal capabilities of clearing intracellular 
infections (Chase et al, 2008; Harris and Barletta, 2001).   MAP is known to subsequently 
survive phagocytosis by macrophages and to replicate intracellularly during a long 
subclinical latency (Harris and Barletta, 2001).  Little is known, however, about immune 
recognition of the pathogen during the neonatal period. 
 Bovine colostrum contains non-nutritive compounds that complement the 
immunosuppressed neonate by providing protection through pathogen neutralization and 
by enabling tolerant responses during immune development (Stelwagen et al, 2009).  
Originally attributed solely to passively transferred IgG1 (Robison et al, 1988), immune 
benefits of colostrum are also attributed to growth factors, cytokines, antimicrobial 
peptides, and leukocytes found in the mammary secretion (Stelwagen et al, 2009).  
Collectively, non-nutritive compounds in colostrum promote TH2-biased immune 
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responses to early microbial encounters and prevent harmful, inappropriate inflammation 
in neonatal tissues (Chase et al, 2008).  Post-natal, nutritional influences such as 
increased dietary energy and protein or vitamin A, D3, or E deficiencies may cause 
dysregulation of immune signaling and decreased integrity of immune responses, thus 
compromising neonatal health (Nonnecke et al, 2010; Krueger et al, 2014; Sacco et al, 
2012). 
 The present study was conducted to determine if neonatal bovine leukocyte 
subsets recognize and respond to MAP antigens within the first 14 d of age when passive 
immune protections wane but while endogenous immunity is yet partially naïve.  The 
study was designed to test the hypothesis that colostrum, vitamin supplementation, or 
both nutritional treatments alter mononuclear cell proliferative capabilities and 
subsequent responses to MAP antigens. 
Materials and Methods 
Animals and treatments 
 Thirty Holstein calves were obtained at birth and treated as previously described 
(Krueger et al, unpublished data).  Briefly, calves were colostrum deprived (CD) or fed 
colostrum replacer at birth.  Colostrum replete calves were either not supplemented with 
vitamins (CR), or supplemented with vitamin A (CR-A), vitamin D3 (CR-D), vitamin E 
(CR-E), or all three vitamins (CR-ADE).  All calves were inoculated twice via dietary 
milk with 10
8
 cfu per dose of Mycobacterium avium subsp. paratuberculosis (MAP), 
strain 167 (clinical isolate) during the morning feedings of d 1 and d 3.  Calves were fed 
2.7 L pasteurized whole milk twice daily for 13 d ± 1.  On d 13 ± 1, prior to the morning 
feeding, 20 mL of blood was collected via jugular venipuncture into a syringe containing 
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2x acid-citrate-dextrose (ACD).  Calves were euthanized by barbiturate injection on d 14 
± 1 for tissue collection after a 12 h fast.  All animal procedures were approved by the 
Animal Care and Use Committee, National Animal Disease Center, Ames, IA 50010.   
Isolation and culture of peripheral blood and lymphoid tissue mononuclear cells 
Peripheral blood mononuclear cells (PBMC) were isolated from the buffy-coat 
fractions of the peripheral blood that was collected from the jugular vein in 2X ACD 
(1:10). These cells were resuspended to 2 X 10
6
/mL in complete medium consisting of 
RPMI-1640 with 2 mM L-glutamine and 25 mM HEPES (Gibco, Grand Island, NY) and 
supplemented with 10% fetal calf serum (Gibco), 100 µg/mL streptomycin sulfate 
(Gibco), and 0.25 µg/mL amphotericin B (Gibco).  A mesenteric lymph node associated 
with the mid-jejunum was obtained at necropsy from each calf.  Mid-jejunum was 
identified by tracing the small intestine from the ileum towards the duodenum 
approximately 1.5 m until the mesenteric lymph node chain was observed.  The lymph 
node was rinsed with 0.15 M phosphate-buffered saline (PBS), followed by 
homogenization in RPMI-1640 using a gentle-MACS Octo Dissociator with C tubes to 
disrupt the tissue (Miltenyi Biotech, San Diego, CA 92121).  Cells were resuspended to 
2.0 x 10
6
 cells per mL with complete RPMI-1640 medium. 
Mononuclear cells were cultured in duplicate in 48-well flat-bottomed plates 
(Nunc Technologies, Rochester, NY) with medium alone (nonstimulated (NS)) and 
phytohemaglutinin (PHA; 10 µg/mL; Sigma) for 3 d.  Separately, cells were cultured for 
6 d with either NS or a whole cell sonicate of MAP (MPS; 10 µg/ml), prepared as 
described by Stabel et al
 
(2011).  Cultures were incubated at 39°C, 5% CO2 in a 
humidified atmosphere. 
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Flow cytometry 
PBMC and MNL were analyzed by flow cytometry as fresh cells or after 3 d or 6 
d in culture.  Cultured cells were dislodged from the flat bottom plate by vigorously 
pipetting up and down in the wells.  Cells were fixed in duplicate with primary 
monoclonal antibodies and secondary isotype-specific fluorochromes, or with directly-
conjugated monoclonal antibody-fluorochrome complexes, using three panels as 
described in Table 5.  All primary antibodies were obtained from Washington State 
University (Pullman, WA), and all secondary fluorochromes were obtained from 
Southern Biotech (Birmingham, AL), with the exception of both Alexa350 isotypes, 
which were purchased from Invitrogen (Grand Island, NY). Monoclonal antibodies 
DEC205 and BAQ29 were conjugated in house to Oregon Green and Pacific Orange, 
respectively, using commercial kits (Oregon Green
®
 488 Protein Labeling Kit, Life 
Technologies; Pacific Orange
TM
 Antibody Labeling Kit, Life Technologies). Other 
monoclonal antibody-fluorochrome complexes were purchased from commercial sources 
and included BAQ29A-PE (Becton-Dickinson) CD14-Pacific Blue (Serotec, Raleigh, 
NC), CD26-Alexa647 (Serotec), and CD335-PE (Serotec).  
In a 96-well round bottom plate (Nunc), 50 uL of the cell suspension was added to 
wells containing 50 µL of primary antibody cocktail.  Cells then were incubated for 15 
min at 25°C.  Following incubation, plates were centrifuged at 400 x g for 2 min, and the 
supernatant was decanted.  A secondary antibody cocktail (50 µL per well) containing 
isotype-specific fluorochromes was added to appropriate wells, and then incubation, 
centrifugation, and aspiration procedures were repeated.  The plate was washed with 
PBS, centrifuged, aspirated twice, and then antibody-fluorochrome conjugates were  
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Table 5:  Array and concentration of M-ab, secondary fluorochromes, and direct M-ab-fluorochrome 
conjugates used in the flow cytometric assay. 
 
Surface  
Marker 
 
MC 
Subset 
 
 
Panel 
 
 
M-ab 
 
 
Isotype 
 
 
µL/mL 
 
Secondary 
Fluorochrome 
M-ab- 
Fluorochrome- 
Conjugate 
CD4 TH
 
1 GC50A1 IgM 15 PE-Cy7  
CD8 TC 2 BAQ111A IgM 15 PE-Cy7  
CD14 Monocyte 1,2 *  12  Pac-Blue 
IgM B cell 1 PIG45A IgG2b 10 Alexa350  
γδTCR γδ T cell 2 GB21A IgG2b 10 Alexa350  
CD205 Dendritic 3 DEC205  20  FITC 
CD335 NK 3 *  15  PE 
CD25  1,2,3 CACT108A IgG2a 15 PE-Cy5  
CD26  1,2,3 *  15  Alexa647 
CD44  1,2 BAT31A IgG1 10 FITC  
  3 BAT31A IgG1 10 Alexa350  
CD45RO  1,2,3 ILA116 IgG3 5 APC-Cy7  
CD62L  1,2 BAQ29A  20  PE 
  3 BAQ29A  20  Pac-Orange 
*
Purchased as direct conjugate, undisclosed clone.  M-ab, monoclonal antibody; CD, cluster of 
differentiation; MC, mononuclear cell; Ig, immunoglobulin.   
 
added to appropriate wells, incubated, centrifuged, and decanted as described.   Cells 
were resuspended in 200 µL StableFix buffer (Becton-Dickinson).  Duplicate wells were 
combined and then were analyzed (10,000 events) by a FACScan flow cytometer (Model 
LSRII, Becton-Dickinson) for forward scatter intensity (FSC-A), side scatter intensity 
(SSC-A), and fluorescent intensity of each conjugated fluorochrome.  
Raw data were plotted in FCS Express 3 (De Novo Software, Glendale, CA 
91203).  For each leukocyte sample, SSC-A was plotted against FSC-A to select for MC.  
Within the MC subset, SSC-A was plotted against the fluorescent intensity of each 
antibody-conjugated fluorochrome.  Mononuclear cells positively expressing a given 
fluorochrome were determined to belong to the respective subset (Figure 6).  CD205 
(dendritic cells), CD335 (natural killer cells), CD26, CD44, and CD62L were less 
distinguishable by fluorochrome expression and are not reported.  For each MC subset, 
mean fluorescent intensity (MFI) and percentage of MC were determined. 
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MC subsets were identified by detection of a fluorochrome conjugated to a surface molecule. 
CD205
+
 and CD335
+
 subsets were not clearly identifiable, as were CD26
+
, CD44
+
, and CD62L
+ 
(not shown). MC, mononuclear cells; CD, cluster of differentiation; SSC-A, side scatter 
absorbance; IgM, immunoglobulin M; gdTCR, !" T cell receptor. 
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Figure 6. Identificati  of MC subsets. MC subsets were dentified by tection of a fluorochrome 
conjug ted to a surface molecule. CD205
+
 and CD335
+
 subsets were not clearly identifiable, as were 
CD26
+
, CD44
+
, and CD62L
+ 
(not shown). MC, mononuclear cells; CD, cluster of differentiation; 
SSC-A, side scatter absorbance; IgM, immunoglobulin M; gdTCR, γδ T cell receptor. 
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Statistical analysis 
Data were analyzed using mixed procedures of SAS (version 9.3, SAS Institute 
Inc., Cary, NC).  Fresh PBMC, fresh MNL, 3 d PBMC, 3 d MNL, 6 d PBMC, and 6 d 
MNL were all analyzed separately.  Percentage of cells belonging to each subset was 
analyzed as a function of vitamin treatment and in vitro treatment, which were fixed 
effects in the model; calf was included in the model as a random effect and served as the 
experimental unit.  F < 0.1 for either fixed effect in the ANOVA warranted further use of 
contrast statements to compare respective nutritional or in vitro treatments against the 
appropriate control. Data are reported as mean ± SEM.  Differences between least 
squares means were significant when P < 0.05.  
Results 
 Mononuclear cells in peripheral blood and the mesenteric lymph node were 
analyzed by flow cytometry to determine the distribution of lymphocyte subsets.  CD4
+
, 
CD8
+
, γδTCR+, IgM+, and CD14+ cells as percentages of PBMC and MNL across calf 
treatment groups are stated in Table 6.  CD14
+
, CD4
+, and γδTCR+ subsets were most 
abundant among PBMC, averaging 25.4 ± 1.7, 17.0 ± 1.6, and 16.6 ± 3.0 %, respectively.  
In contrast, CD4
+
 and IgM
+
 lymphocytes were the predominant subsets observed in 
mesenteric lymphoid tissue, averaging 32.2 ± 1.5 and 24.9 ± 2.1 %, respectively.  γδ T 
cells were the least abundant subset among MNL, averaging only 6.4 ± 0.9 %.  γδ T cells 
expressing CD25 thus were identified as a predominant lymphocyte subset in peripheral 
blood. 
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Figure 7: γδ T cells in PBMC. γδ T cells comprised a lower 
proportion of fresh PBMC in CD calves than in all other CR 
calves. *P < 0.01 for CD compared with CR, CR-A, CR-D, 
CR-E, CR-ADE.  PBMC, peripheral blood mononuclear 
cells; CD, colostrum deprived; CR, colostrum replete; A, 
supplemented with vitamin A; D, supplemented with 
vitamin D3; E, supplemented with vitamin E. 
 
 
Table 6: Mononuclear cell percentage distribution in peripheral blood and mesenteric lymph node.  
 CD4
+ 
CD8
+ γδ TCR+ IgM+ CD14+ 
 Mean SE Mean SE Mean SE Mean SE Mean SE 
PBMC 17.0 1.2 9.8 0.9 16.6 3.0 8.2 0.9 25.4 1.7 
MNL 32.2 1.5 14.9 0.8 6.4 0.9 24.9 2.1 27.3 1.5 
PBMC, peripheral blood mononuclear cells; MNL; mesenteric lymph node mononuclear cells, CD, cluster 
of differentiation, TCR, T cell receptor; Ig, immunoglobulin.  
 
Effects of nutritional treatments 
on lymphocyte distribution in 
fresh PBMC and MNL were 
then assessed.  As shown in 
Figure 7, γδ T cells comprised a 
lower percentage of PBMC (P < 
0.01) in colostrum-deprived 
(CD) calves than in calves fed 
colostrum replacer with or 
without supplemental vitamins.   
CD calves also exhibited increased percentages of CD4
+
 (P < 0.05) and CD8
+
 (P < 0.005) 
T cells than all other CR calves (data not shown), averaging 25.3 ± 3.8 and 15.9 ± 2.0 %, 
respectively, for CD calves compared with 15.3 ± 1.7 and 8.6 ± 0.9 %, respectively, for 
CR calves.  In fresh PBMC, γδ T cells expressed the greatest abundance of CD25, with 
this lymphocyte subset expressing CD25 at 4.6 times the intensity (P < 0.001) of other 
mononuclear cells (Figure 8a).  Lymphoid γδ T cells also expressed CD25 more 
abundantly (P < 0.001) than did other MNL, but at only 1.4 times the intensity (Figure 
8b).   
* 
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Figure 8.  CD25 on γδ T cells. Cells positively 
expressing γδ T cell receptor were analyzed for co-
expression of CD25.  A. γδ T cells in peripheral blood 
expressed IL-2 receptor at 4.6x intensity of other PBMC.  
B. Lymphoid γδ T cells expressed IL-2 receptor at 1.4x 
intensity of other MNL.  PBMC, peripheral blood 
mononuclear cells; MNL, mesenteric lymph node 
mononuclear cells.  Different superscripts are different, P 
< 0.001. 
 
Expression of CD45RO was measured within lymphocyte subsets to estimate 
antigen-activated memory response capabilities.  Among PBMC, CD45RO was 
positively expressed on 39.2 ± 4.3, 28.1 ± 1.8, 98.6 ± 0.3 and 21.8 ± 6.8 % of CD4
+
, 
CD8
+
, and γδTCR+, and B cells, respectively, but expression was not affected by  
nutritional treatment.  CD45RO 
was present on 47.6 ± 2.8, 27.6 ± 
1.5, 91.6 ± 1.2, and 56.3 ± 6.3% 
of lymphoid CD4
+
, CD8
+
, 
γδTCR+, and B cells, respectively. 
γδ T cells thus were further 
identified as key responders in 
both peripheral blood and 
lymphoid tissue. 
 PBMC and MNL were 
cultured with PHA mitogen to 
determine the proliferative 
capability of each lymphocyte 
subset.  Culture for 3 d with PHA 
(Figure 9) induced proliferation 
among PBMC of CD4
+
, CD8
+
, 
and IgM
+
 lymphocyte subsets, 
which increased from 13.2 ± 1.7 to 24.1 ± 2.7 (P < 0.001), from 10.8 ± 0.8 to 16.5 ± 2.0 
(P < 0.001), and from 25.1 ± 2.2 to 35.2 ± 2.5 (P < 0.001) %, respectively.  In contrast, 
a 
a 
b 
b 
B. 
A. 
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peripheral γδ T cells decreased from 23.3 ± 2.0 to 9.5 ± 1.4 % (P < 0.001).  MNL were 
less affected by culture with PHA; only IgM
+
 cells were increased significantly from 30.0 
± 2.2 to 38.4 ± 2.3 % (P < 0.001, data not shown).  Proliferative differences across 
nutritional treatments were not detected (P < 0.05). 
 
 
 
 
Cells were cultured separately with MPS for 6 d to evaluate sensitivity to antigens 
of the inoculated pathogen.  PBMC exhibited a response characterized by increased B 
lymphocyte and decreased T lymphocyte percentages (Figure 10).  CD4
+
, CD8
+
, and γδ T 
cells all decreased as a percentage of PBMC by approximately 24.2 (P < 0.01), 33.6 (P < 
0.001), and 18.8 % (P < 0.001), respectively, whereas B cells increased by approximately 
28.4% (P < 0.001).  MNL were affected differently by culture (Figure 11) with MPS;  
** 
* 
** 
** 
Figure 9.  PBMC profile after 3 d culture with PHA. Exposure to PHA increased the percentage of 
CD4
+
, CD8
+, and B lymphocytes, but decreased the percentage of γδ T cells among PBMC.  *P < 
0.0005, **P < 0.0001.  NS, no stimulation control; PHA, lectin of Phaseolus vulgaris; MC,  
mononuclear cells; PBMC, peripheral blood mononuclear cells; CD, cluster of differentiation; γδ, 
γδ T cells; IgM, immunoglobulin M.  
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Figure 11: MNL profile after 6 d culture with MPS.Exposure to MPS decreased the percentages of 
CD4
+
 and CD8
+
 T cells, but increased the percentages of γδ T cells and B lymphocytes among MNL.  
*P < 0.001, **P < 0.0001.  NS, no stimulation control; MPS, whole cell sonicate of Mycobacterium 
avium subsp. paratuberculosis; MC,  mononuclear cells; LMC, lymphoid mononuclear cells; CD, 
cluster of differentiation; γδ, γδ T cells; IgM, immunoglobulin M. 
 
* 
*** 
*** ** 
** 
** 
** 
* 
Figure 10. PBMC profile after 6 d culture with MPS. Exposure to MPS decreased the percentages of 
CD4
+
, CD8
+
, and γδ T cells, but increased the percentage of B lymphocytes among PBMC.  *P < 0.01, 
**P < 0.001, ***P < 0.0001.  NS, no stimulation control; MPS, whole cell sonicate of Mycobacterium 
avium subsp. paratuberculosis; MC,  mononuclear cells; PBMC, peripheral blood mononuclear cells; 
CD, cluster of differentiation; γδ, γδ T cells; IgM, immunoglobulin M. 
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CD4
+
, CD8
+
, and B lymphocyte subsets responded similarly to their peripheral 
counterparts, but γδ T cells increased from 7.4 ± 0.7 to 13.4 ± 1.4 % of MNL (P < 0.001). 
Discussion 
 Results of this study demonstrate that γδ T lymphocytes are key participants in 
neonatal immunity.  A primary observation is that this mononuclear subset intensely 
expresses CD25, the interleukin-2 (IL-2) receptor, in peripheral blood and that CD calves 
exhibit decreased percentages of γδ T cells among PBMC within the first two weeks of 
life.  Mononuclear lymphocytes are known to be present in mammary gland secretions 
before parturition and through the end of lactation
 
(Park et al, 1992).  However, the 
pasteurization, fractionation, and spray-drying procedures involved in manufacturing the 
colostrum replacer used in this study exclude the possibility that viable, maternal, 
leukocytes were acquired passively by the calf.  Thus, one or more compounds in 
colostral whey may have affected the proportion of γδ T cells in peripheral blood in 
calves, likely through an indirect mechanism involving activation of an immune 
response.  In contrast, no effect of vitamin supplementation was observed on lymphocyte 
distribution, proliferative ability, or MPS sensitivity.  Vitamins A, D3, and E have been 
implicated in various roles pertaining to TH1 signaling and T cell receptor sensitivity 
(Nonnecke et al, 2010; Sacco et al, 2012).  The TH2-like IgM
+
 B cell response to MPS 
suggests that these roles may be less involved in recognition of this pathogen.    
 Lymphoctye populations in neonatal calves have been studied extensively.  As 
reviewed by Chase et al (2008), IgM
+
 B cells may comprise less than 5% of circulating 
lymphocytes, but early antigen encounters stimulate clonal expansion of this subset 
within weeks.  Young calves that were experimentally infected intratonsillarly with MAP 
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from 2-5 weeks of age exhibited humoral reactivity to a ~50 kDa antigen of MPS (Waters 
et al, 2003), and calves exhibit B cell responses to the pathogen by 3 mo. of age (Stabel et 
al, 2011), thus demonstrating capabilities for early response.  CD4
+ 
and CD8
+
 T cells are 
known to comprise about 20% and 10% of peripheral neonatal lymphocytes, respectively, 
and maintain a 2:1 ratio of relative abundance through adulthood (Chase et al, 2008); 
findings of the present study agree with previous reports.  In further agreement with the 
present findings, γδ T cells are known to make up about 25% of circulating neonatal 
lymphocytes and to decrease in relative abundance during the first 5 mo of age.  γδ T 
lymphocytes are among the first cells recruited to subcutaneous sites of experimental 
MAP infection in 5-6 week old calves (Plattner et al, 2012).  Identification of this T cell 
subset as a key responder during early infection is thus not unprecedented. 
 The identification of increased CD25 expression among peripheral γδ T cells 
indicates that abundance of this lymphocyte subset in neonates might be linked to IL-2 
signaling.  Indeed, when PBMC were cultured with PHA for 3 d, a proliferative response 
of CD4
+
 CD8
+
, and IgM
+
 lymphocytes was observed, but γδ T cells declined as a 
percentage of PBMC.  No attempts were made to isolate any of the lymphocyte subsets 
for quantification of proliferating cell nuclear antigen or caspases that would further 
identify the percentage changes as proliferative or apoptotic in nature, nor were cytokine 
secretions measured.  The percentage changes of CD4
+
 and CD8
+
 T cells observed in 3 d 
culture, however, agree with previous observations that PHA is a lymphocyte mitogen 
that induces TH1 cytokine signaling
 
(Lis and Sharon, 1977; Epstein et al, 1971).  
Interleukin-2 is the principal cytokine responsible for T cell proliferation and is the first 
to be secreted upon T cell activation (Abbas et al, 2012).  Furthermore, γδ T cells have 
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been shown to proliferate in an IL-2-mediated autocrine fashion in response to M. 
tuberculosis antigen (Janis et al, 1989).  The greater relative intensity with which fresh γδ 
T cells expressed CD25 compared with other PBMC thus indicates that these cells were 
activated prior to PHA stimulation, whereas other T and B lymphocytes were activated 
only upon mitogen treatment.  Thus, the apparent paucity of peripheral γδ T cells among 
fresh PBMC in CD calves and among PBMC of all calves after mitogen treatment should 
not be interpreted as γδ T cell inadequacy, but rather as an indication that other 
lymphocyte subsets were activated for proliferation. 
 Two mechanisms potentially explain the lower percentage of γδ T cells in CD 
calves.  The whey fraction of colostrum, which comprised the colostrum replacer used in 
this study, contains biologically active, non-nutritive compounds, including IgG1 
antibodies, complement, and cytokines (Stelwagen et al, 2009).  Collectively, these 
compounds promote TH2-biased immunity in the neonate to accommodate microbial 
exposure at birth (Chase et al, 2008).  In the absence of colostrum, neonatal calves lack 
the adaptive, neutralizing defenses of passively acquired immunity and are at increased 
risk for pathogen stimulation of pro-inflammatory TH1 responses.  This first mechanism, 
however, cannot completely account for the apparent TH1 activation observed; acute 
phase proteins indicative of endogenous inflammation were not different at d 7 or d 14 of 
age in CD and CR calves in this study (Krueger et al, unpublished data).  Only at d 1 of 
age were acute phase proteins different, as CD calves failed to acquire haptoglobin in the 
first 24 h of life.  Haptoglobin has been shown to participate in antigen presentation and 
generation of antibody-mediated recall responses (Huntoon et al, 2008).  Thus, evidence 
supports a secondary mechanism by which haptoglobin and other non-nutritive colostral 
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compounds divert neonatal immune signaling to a TH2 bias under which γδ T cells remain 
a predominant cell type. 
Stimulation of PBMC for 6 d with MPS did not result in shifts in T lymphocyte 
percentages similar to stimulation by PHA.  Instead, CD4
+
, CD8
+
, and γδ T cells all 
decreased as a percentage of PBMC, whereas IgM
+
 B cells increased.  B cell proliferation 
without concurrent expansion of T cell subsets suggests a TH2 cytokine response to MPS.  
Interestingly, the percentage of lymphoid γδ T cells was expanded in response to MPS 
while percentage changes of other lymphocyte subsets were similar to those of PBMC.  
The contradictory responses of peripheral and lymphoid γδ T cells are possibly explained 
by the lower relative expression of CD25 by fresh lymphoid γδ T cells compared with 
those among PBMC.  Whereas fresh peripheral γδ T cells were hyper-expressive for 
CD25, indicating an antigen-activated state, lymphoid γδ T cells were less activated prior 
to antigen stimulation.  Culture with MPS induced expansion of the lymphoid γδ T cell 
subset, which is indicative of IL-2 autocrine signaling amid a TH2 response.  This 
dynamic result further implies that neonatal lymphoid γδ T cells are primed for broader 
participation in TH2-biased responses during immune development.      
 Results of this study agree with previously reported data characterizing γδ T cells 
in the bovine neonate.  γδ T cells can become primed by pathogen-associated molecular 
patterns for increased responsiveness to IL-2 without becoming fully activated (Jutila et 
al, 2008).  Furthermore, γδ T cells are a predominant lymphocyte subset in bovine 
neonates and can participate in early pro-inflammatory responses by secreting interferon-
γ (IFN-γ) (Taschuk and Griebel, 2012; Ramsburg et al, 2003).  Responses of this 
specialized T lymphocyte subset to intracellular infection, especially by Mycobacterium 
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species, have been intensely studied.  γδ T cells proliferate in response to M. tuberculosis 
antigens through an IL-2-mediated mechanism (Janis et al, 1989; Constant et al, 1994).   
Subsequent activation by non-peptide mycobacterial antigens induces IFN-γ and is 
enhanced by IL-12 (Garcia et al, 1997).  Interestingly, IL-12 secretion is suppressed in 
the neonatal calf by endogenous and maternal glucocorticoids (Chase et al, 2008; Visser 
et al, 1998).  Conclusions from these studies ultimately support a role for γδ T cells in 
defense against intracellular pathogens that is independent of inflammation, which 
highlights the importance of the subset in TH1-suppressed neonatal calves.    
Conclusions 
 Colostrum-deprived calves have decreased γδ T cell percentages among PBMC, 
which indicates increased TH1 immune signaling during early life.  γδ T cells of young 
calves express IL-2 receptor and CD45RO more intensely than other MC, but do not 
further proliferate in response to PHA; thus, γδ T cells may be activated independently of 
inflammation and are likely a key effector subset during TH2-biased neonatal immune 
development.  Neonatal lymphoid γδ T cells retain capacity for antigen-provoked 
proliferation and respond to Mycobacterial antigen in vitro amid a broader TH2-like 
response.   
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CHAPTER 4 
MYCOBACTERIUM AVIUM, SUBSP. PARATUBERCULOSIS INFECTION AND 
INTESTINAL MICROBIOTA COMMUNITY STRUCTURE IN HOLSTEIN 
CALVES TREATED WITH COLOSTRUM AND FAT-SOLUBLE VITAMINS 
 
Abstract 
 Thirty Holstein calves were assigned randomly at birth to one of six treatment 
groups: 1) colostrum deprived (CD), no vitamins; 2) colostrum replacer (CR), no 
vitamins; 3) CR, vitamin A; 4) CR, vitamin D3; 5) CR, vitamin E; 6) CR, vitamins A, D3, 
and E, with 5 calves per treatment in a 14 d study.  Calves were injected with appropriate 
vitamin supplements and fed pasteurized whole milk (CD calves) or fractionated 
colostrum replacer (CR) at birth.  Thereafter, all calves were fed pasteurized whole milk 
fortified with vitamins according to treatment.  Calves were orally inoculated with 10
8
 
cfu of Mycobacterium avium subsp. paratuberculosis (MAP) on d 1 and 3 of age.  Feces 
were collected on d 7, and calves were euthanized on d 14 for collection of 22 intestinal 
tissues.   
 Calves in all groups were found to shed MAP into feces on d 7 of age, and MAP 
colonized in distal jejunum, ileum, and ileo-cecal valve, but differences among nutritional 
treatments were not observed.  Differences between lumen and mucosal microbial 
communities were observed, but were not different among nutritional treatments.  
Combined intestinal communities of CR-D and CR-E calves were distinct and were 
related to clinical observations of health.  Colostrum-deprived calves exhibited increased 
richness compared with CR calves in the cecum and spiral colon, and were found to 
harbor increased Proteobacteria and decreased Bacteroidetes in the spiral colon mucosa 
compared with the lumen.  Disparity between lumen and mucosal communities in the 
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large intestine did not correlate with increased health and likely represents dysbiosis 
caused by aberrant immune regulation. 
Introduction 
 Johne’s disease is a chronic, pathogenic gastroenteritis caused by Mycobacterium 
avium, subsp. paratuberculosis (MAP) that causes malnourishment and wasting in both 
beef and dairy cattle worldwide (Harris and Barletta, 2001).  MAP has been estimated to 
cause financial loss to United States dairy producers estimated at $40 to $227 per 
inventoried cow though decreased milk production and increased cull rates (Wilson et al, 
1993).  Efforts to mitigate disease propagation have focused on preventing infection in 
the neonate by maintaining a clean birthing environment and pasteurizing colostrum and 
milk (Stabel, 2008; Stabel et al, 2014), and by slowing disease progression through the 
use of a commercial vaccine (Stabel et al, 2011).  Studies of pathology during neonatal 
infection have explored endogenous humoral responses as early as 3-5 weeks of age 
(Mortier et al, 2014b), but early infection remains largely uncharacterized in calves 
inoculated around the time of parturition. 
 Neonatal calves are immune-suppressed by maternal influences during late 
gestation and are additionally influenced by post-natal nutrition via lactocrine 
mechanisms, which favor TH2 signaling (Chase et al, 2008; Bartol et al, 2008).  TH2 
immunity also characterizes progression to the advanced stage of Johne’s disease in adult 
animals after a long latency, during which MAP is controlled by TH1 responses (Harris 
and Barletta, 2001).  Thus, natural immune suppression may favor MAP infection.  TH1 
and TH2 immune responses are more widely recognized in neonatal physiology for 
interaction with pathogens that cause acute, rather than chronic, distress.  Colostrum is a 
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nutritive staple of commercial calf husbandry that is known to provide immunoglobulin 
G1 (IgG1) and other bioactive immune factors for passive transfer of immunity 
(Stelwagen et al, 2009).  Colostrum biases immunity toward TH2 signaling and increases 
disease resistance and survival (Chase et al, 2008; Robison et al, 1988).  The period of 
time during which passively transferred immunity wanes, but endogenous immunity 
remains immature, is a critical window of opportunity for pathogen opportunism.  
Neonatal susceptibility to disease during this window has been further linked to vitamin 
A, D3, and E dietary adequacy (Nonnecke et al, 2014; Krueger et al, 2014). 
 Vitamins A, D3, and E, and the many bioactive compounds in colostrum are 
known to affect epithelial maturation, membrane integrity, gene expression, and immune 
regulation that may collectively relate to microbial colonization in the intestine (Nelson et 
al, 2012; Rhinn and Dollé, 2012; Hall et al, 2011; Traber and Atkinson, 2007; Stelwagen 
et al, 2009).  Thus, the following study was conducted to characterize neonatal MAP 
infection and microbial colonization of the intestine in calves supplemented with 
colostrum and fat-soluble vitamins with the hypothesis that supplementation of each 
dietary component would enable calves to differently regulate the intestinal environment 
for increased health. 
Materials and Methods 
Animals and treatments 
 Thirty Holstein calves were obtained at birth and treated as previously described 
(Krueger et al, unpublished data a, b).  Briefly, calves were obtained from two dairy 
farms in central Iowa at birth and randomly assigned to one of six treatment groups: 1) 
colostrum deprived (CD), no vitamins; 2) colostrum replacer (CR), no vitamins; 3) 
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colostrum replacer, vitamin A (CR-A); 4) colostrum replacer, vitamin D (CR-D); 5) 
colostrum replacer, vitamin E (CR-E); 6) colostrum replacer, vitamins A, D, E (CR-
ADE), with 5 calves per treatment in a 14 d study.  Within 3 h of birth, calves were fed 
colostrum replacer (Milk Products, Chilton, WI) or pasteurized whole milk (PWM, Iowa 
State University Dairy Farm, Ames, IA) as a control.  At the time of first feeding, calves 
were also injected with respective vitamin supplements or a placebo (Stuart Products, 
Inc., Bedford, TX).  Then, calves were fed PWM fortified with vitamins or placebo 
according to treatment twice daily for 13 d ± 1.  Calves were orally inoculated on d 1 and 
d 3 with 10
8
 cfu Mycobacterium avium, subsp. paratuberculosis (MAP), strain 167 
(clinical isolate, National Animal Disease Center, Ames, IA) per dose.  Feces were 
collected on d 7 and d 14 and stored at -80°C.  All animal procedures were approved by 
the Animal Care and Use Committee, National Animal Disease Center.   
 Calves were euthanized after a 12 h fast on d 14 ± 1 for collection of 22 tissues, 
which included duodenum, proximal jejunum, mid-jejunum, distal jejunum, ileum, ileo-
cecal valve, spiral colon, transverse colon, descending colon, and lymph nodes of each 
region, as well as cecum, liver, spleen, and the jejunal mesenteric lymph node chain.  
Lumen contents of mid-jejunum, ileum, cecum, spiral colon, and descending colon were 
drained from respective tissues, collected into 15 mL conical tubes and placed on ice, 
followed by storage at -80°C.  Tissues were rinsed with 0.15 M phosphate-buffered saline 
(PBS) and cut into multiple cross-sections.  Cross-sections of mid-jejunum, ileum, 
cecum, and spiral colon were opened to expose the mucosa, and a sterile glass slide was 
used to scrape the mucosal surface.  Mucosal scrapings were collected into a 1.5 mL 
Eppendorf tubes and stored at -80°C until analyses could be performed.  One cross-
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section from each tissue was fixed in 10% Zn-formalin for histopathology (CB Formalin, 
Anatech, Ltd., Battle Creek, MI).  Additional sections of tissues were stored at -80°C for 
culture of MAP.   
Histopathology 
 Tissues fixed in formalin were cut into cross-sections, embedded in paraffin, cut 
at 4-6 µm, and stained by using the Ziehl-Neelsen technique for visualizing acid-fast 
bacteria.  Tissues were viewed under a microscope and assigned lesion scores on a scale 
of 0 to 5, where 0 represented no acid fast organisms per section and 5 represented nearly 
diffuse staining with acid fast organisms. 
MAP culture 
 Fecal samples (2 g) were obtained at d 7 and 14 and then processed by a 
centrifugation and double-decontamination procedure (Stabel, 1997).  Decontaminated 
samples (200 µL) were dispensed onto Herrold’s Egg Yolk medium (HEYM) and 
incubated at 39°C for 12 weeks.  Tissues obtained at necropsy were homogenized in 
0.9% hexadecylpyradinium chloride solution with a gentleMACS
TM
 Octo Dissociator, 
using M tubes (Miltenyi Biotec, San Diego, CA).  Following overnight incubation, 
homogenates were pelleted by centrifugation at 900 x g for 30 min and re-suspended in 
antibiotic medium containing 100 µg/mL nalidixic acid, 100 µg/mL vancomycin, and 50 
µg/mL amphotericin B (Sigma).  Samples were incubated overnight and then inoculated 
onto 4 slants of HEYM
 
(Pithua et al, 2011).  Slants were incubated at 39°C for at least 12 
weeks, and colony counts of viable MAP were recorded and averaged for the four slants.  
Confirmation of MAP colonies was performed by picking colonies off the HEYm slants, 
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boiling in ultra-pure water
TM
 distilled water (Life Technologies) to release the DNA, 
followed by IS900 PCR as described below. 
DNA extraction and PCR 
DNA from fecal samples was extracted by using the Ambion
®
 Mag Max
TM
 total 
nucleic acid isolation kit (Life Technologies, Grand Island, NY) according to 
manufacturer’s recommendations in conjunction with a Mag MaxTM Express processor 
(AM1840 v2, Applied Biosystems, Life Technologies).  DNA was extracted from tissues 
by using modified procedures of the UltraClean
®
 tissue & cells DNA isolation kit (Mo 
Bio Laboratories, Inc., Carlsbad, CA).  Briefly, 100 mg of tissue was placed into a 2 mL 
screw cap vial, which contained 0.5 mL silica beads (0.1 mm diameter, BioSpec 
Products, Bartlesville, OK), 700 µL of TD1 buffer (Mo Bio) and 20 µL proteinase K 
(Qiagen, Valencia, CA).  Samples were vortexed for 10 min, incubated at 60°C for 1 h, 
and then UltraClean
® kit procedures were performed according to manufacturer’s 
instructions.  
Total DNA was extracted from lumen contents of mid-jejunum, ileum, cecum, 
spiral colon, and descending colon, and mucosal scrapings of mid-jejunum, ileum, 
cecum, and spiral colon for quantitative amplification of the IS900 gene and 
amplification of the 16S ribosomal gene for phylogenetic sequencing.  Samples (about 
300 mg) were homogenized by using a gentleMacs
TM
 Octo Dissociator with M tubes 
(Miltenyi Biotec) containing 2.0 mL ATL buffer (Qiagen).  Homogenates were 
transferred to a 12 x 75 mm tube and loaded onto a rotating mixer and incubated 
overnight with 50 µl proteinase K per 250 mg sample (Qiagen) at 56°C.  Then, DNA was 
extracted by using the PowerMag
TM
 Microbiome RNA/DNA Isolation Kit
®
 (Mo Bio 
90 
 
 
Laboratories, Inc.) according to manufacturer’s instructions.  A Biomek® FXP 
Laboratory Automation Workstation with DTX 880 mulitmode detector (Beckman 
Coulter, Inc., Indianapolis, IN) was utilized for magnetic separation of DNA-binding 
beads and wash and elution procedures.   
Semi-quantitative PCR was performed for the detection of the IS900 target gene 
as previously described
 
(Leite et al, 2013), with the exception that TaqMan 
Environmental Master Mix (Applied Biosystems, Foster City, CA) was used in the 
reaction.  Additionally, for lumen contents and mucosal scrapings, the V1 through V3 
region of the 16S bacterial ribosomal gene was amplified by PCR.  Extracted samples 
were quantified by using a Nanodrop 8000 spectrophotometer (Thermo Scientific, 
Waltham, MA) and DNA concentration in each sample was brought to 500 ng/µL in 
water.  Reaction conditions, generic construction of primers, and the SC and SD index 
sequences used in the present study have been described by Kozich et al
 
(2013), but 
primer sequences specific to the V1 and V3 regions are described by Looft et al (2014), 
and pad adaptor sequences were modified according to manufacturer’s specifications for 
the MiSeq Gene and Small Genome Sequencer (Illumina, San Diego, CA). 
PCR clean-up 
 Products of each reaction, which were unique to respective samples, were loaded 
into individual wells on a SequalPrep
TM
 Normalization Plate (Invitrogen, Life 
Technologies) and standardized to approximately 1 ng/µL according to manufacturer’s 
instructions.  Wells of each of four plates were combined into four respective libraries so 
that reaction product of each sample was evenly represented in the respective library.  A 
sample from each library was loaded onto a High Sensitivity DNA chip (Agilent 
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Technologies, Santa Clara, CA) and examined with an Agilent 2100 Bioanalyzer System 
(Agilent Technologies).  Each of the four libraries was found to contain a ~625 bp 
product consistent with expected length of the 16S target amplicon, but also a nearly 
equimolar ~130 bp product consistent with the expected length of dimerized primers 
from the PCR reaction.  The ~130 bp amplicon was eliminated by electrophoretic 
separation of raw PCR product on 1% agarose gels followed by excision of reaction 
products at ~625 bp, using a Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine, 
CA) according to manufacturer’s recommendations and quantification via the Quant itTM 
PicoGreen
®
 according to manufacturer’s instructions.  Extracted samples were re-pooled 
and purity of the ~625 bp product in each library was verified on a High Sensitivity DNA 
chip (Agilent). dsDNA was quantified in each library by qPCR via a KAPA Library 
Quantification Kit (KAPA Biosystems, Wilmington, MA) according to manufacturer’s 
specifications.  Concentration of each library was normalized to the number of 
representative samples, and then libraries were pooled to give dsDNA of each sample 
equal representation in a final, common library, concentrated at 1.86 nM. 
16S sequence data 
 The library of indexed 16S amplicons was sequenced as 2 x 300 paired-end reads 
on a MiSeq
®
 system (Illumina) with 5% PhiX, according to the workflow described by 
Kozich et al
 
(2013).  The MiSeq
®
 system generated 13,098,605 sequences as pairs of 
.fastq files, which were processed by using MOTHUR
 
(Schloss et al 2009) as previously 
described (Kozich et al, 2013).  Briefly, paired-end reads were combined into contiguous 
sequences with approximately 110 bp overlap.  Duplicate sequences were merged into 
unique sequences, which were aligned to a 12,082 bp region (positions 1,043 - 13,125) of 
92 
 
 
the Silva reference database, and were filtered to remove sequences with homopolymers 
of more than 8 bp.   Unique sequences were pre-clustered by merging sequences with up 
to 5 nucleotide differences and classified taxonomically.  Sequences in each sample were 
queried against abundant sequences in other samples and against the Silva.gold.align 
database to identify chimeras.  Chimeric and other sequences corresponding to gene 
fragments other than 16S rRNA were removed, as were sequences found only once 
across all samples.  Screening procedures as described resulted in 1,704,272 unique 
sequences for consensus taxonomic assignment.  Pre-clusters were assigned consensus 
taxonomy as operational taxonomic units (OTU) with 97% similarity.      
Microbial community data analysis 
Unique sequences were assigned consensus taxonomy as OTU and were indexed 
according to sample.  Cecum contents (CC), cecum mucosal scrapings, (CMC), spiral 
colon contents (SCC), spiral colon mucosal scrapings (SCMC), and descending colon 
contents (DCC) were subsampled to 2,761 sequences per sample by using procedures 
previously described
 
(Kozich et al, 2013).  Other samples did not contain enough 
sequences to facilitate sufficient subsampling.  Chao, Inverse Simpson, and Shannon 
indices for each sample were generated by using MOTHUR and compared among 
nutritional treatments, intestinal regions, and sample types by using mixed procedures of 
Statistical Analysis Software (SAS, version 9.3, SAS Institute, Inc., Cary, NC).  
Subsampled communities were compared by the ANOSIM procedure in Paleontological 
Statisitics software, version 3.06 (PAST) (Hammer et al, 2001) and visualized by 
principal coordinate analysis using the Bray-Curtis dissimilarity measure.  Relative 
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abundance of phyla within each region and sample type was analyzed by using mixed 
procedures of SAS, with calf as the experimental unit. 
Results 
MAP infection in neonatal tissues 
 Tissues collected during necropsy were stained and examined microscopically for 
intracellular MAP.  The organism was not identified microscopically in any tissues 
belonging to CD or CR calves.  Sections of each tissue were homogenized and cultured 
on solid media.  Distal jejunum, ileum, and ileo-cecal valve were the most infected 
tissues, with 37, 32, and 16 total colonies isolated, respectively.  No effects of nutritional 
treatments on MAP infection of tissues were observed (Table 7).  Colony counts were 
normalized to cfu/g of tissue and averaged 2.89 ± 1.16, 2.22 ± 0.93, and 1.42 ± 0.37 cfu/g 
in culture-positive samples of distal jejunum, ileum, and ileo-cecal valve, respectively. 
DNA was extracted from each 
tissue, and the IS900 gene was 
quantified by qPCR.  MAP was 
identified in duplicate in 36 of 660 
tissues evaluated, including 6 distal 
jejunum, 4 ileum, 4 ileo-cecal valve, 
and 6 descending colon samples.  No 
differences were detected among treatment groups or tissue types as IS900 was 
undetected in most samples (data not shown).  In samples that were positive for IS900, 
concentration of the gene in extracted DNA averaged 0.71 ± 0.41 fg/µL.  After 
Table 7. Number of calves per group
a
 with culture-
positive result for MAP in intestinal tissues. 
Treatment DJ Ilm ICV 
CD 0 0 0 
CR 1 1 2 
CR-A 2 1 2 
CR-D 1 1 0 
CR-E 1 2 2 
CR-ADE 2 3 1 
a
n=5 per group for each tissue.   
MAP, Mycobacaterium avium, subsp. 
paratuberculosis; CD, colostrum-deprived; CR, 
colostrum-replete; A, supplemented with vitamin A; D, 
supplemented with vitamin D; E, supplemented with 
vitamin E; DJ, distal jejunum; Ilm, ileum; ICV, ileo-
cecal valve. 
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normalizing per g tissue and using a conversion of 5 fg per genome (Moss et al, 1991), 
positive samples were found to harbor an average of 0.47 genomes MAP per g tissue. 
MAP infection in feces and lumen contents  
The IS900 gene was quantified in 
DNA extracted from d 7 feces, d 14 feces, 
mid-jejunum contents, and ileum contents.  
Pass-through of inoculous MAP at d 7 was 
detected in feces of 26 calves and 
quantities were highly variable; 
differences among treatment groups were not observed (Table 8).  One calf of the CR-D 
group was found to shed the IS900 gene at approximately 30.7 ng/µL, but the remaining 
25 calves in which the gene was detected were found to shed 282 ± 138 fg/µL, or 
approximately 188 genomes per g feces.  At d 14, MAP was detected in mid-jejunum 
contents, ileum contents, and feces, collectively, in only 5 calves (data not shown).   
Microbial diversity 
Chao, Simpson, and Shannon indices were used to measure richness, evenness, 
and α-diversity, respectively, in the cecal lumen and mucosa, spiral colonic lumen and 
mucosa, and descending colonic lumen (Figure 12).  Communities of descending colon 
contents were richer (P < 0.05) than combined communities of the spiral colon, but no 
treatment effect was observed on α-diversity in descending colon contents.  Lumen and 
mucosal indices were compared to indicate whether microbial communities were 
distinctly regulated by the calf in the mucosa.  In both the cecum and spiral colon, α-
diversity was not different between the lumen and mucosa, and this finding was  
Table 8. Detection of IS900 in d 7 feces
a
. 
Treatment Mean, fg/µL SEM 
CD 45.8 30.1 
CR 276.2 273.3 
CR-A 52.5 27.33 
CR-D 6,181.9 6,132.1 
CR-E 384.7 149.3 
CR-ADE 681.2 661.9 
a
5 fg/µL equals 3.3 genomes per g feces.  
IS900, insertion sequence 900; CD, colostrum-
deprived; CR, colostrum-replete; A, supplemented 
with vitamin A; D, supplemented with vitamin D; E, 
supplemented with vitamin E. 
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a 
b 
Figure 12: α-Diversity in intestinal samples. Richness, evenness, and α-diversity of microbial 
communities in the lumen and mucosa of cecum and spiral colon and the lumen of descending 
colon were measured by the A) Chao, B) Inverse Simpson, and C) Shannon indices, 
respectively.  A greater value indicates greater richness, evenness, or diversity.  Different 
superscripts are different, P < 0.05. 
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Figure 13: Richness in cecum and spiral colon of CD and CR calves. The Chao 
diversity index was measured in communities of cecum and spiral colon in CD and 
CR calves.  Combined lumen and mucosal indices in each region were compared 
between the two treatment groups.  A greater value means greater richness.  Means 
within the same tissue are different, 
† 
P < 0.1, *P < 0.05. 
 
 
 
 
 
consistent across treatments (data not shown).  Greater richness, however, was observed 
in the combined lumen and mucosal communities of cecum (P < 0.005) and spiral colon 
(P < 0.1) in CD than in CR-supplemented calves (Figure 13).   
Bray-Curtis dissimilarity of microbial communities was further analyzed in PAST 
to determine differences in community structure based on OTU relative abundance, and 
principal coordinates were plotted with 95% confidence (Figure 14).  As shown in Figure 
3, combined communities of CD and CR calves were different (P < 0.05).  Communities 
of CR-A and CR-ADE calves did not differ from one another, but differed (P < 0.05) 
from calves supplemented with vitamin D3.  When lumen and mucosal communities of 
combined nutritional treatments were similarly plotted according to region, additional 
differences in community structure were evident (Figure 15).  Lumen communities of  
* 
† 
† 
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Figure 14: β-Diversity of nutritional treatments. Relative abundance of operational taxonomic units was 
analyzed by principal coordinate analysis using the Bray-Curtis similarity index to determine differences 
in microbial community structure according to nutritional treatment.  Elipses depict 95% confidence with 
respect to samples of the same nutritional treatment.  Communities with different superscripts are 
different, P < 0.05.  Red, CD; Black, CR; Orange, CR-A; Purple, CR-D, Blue, CR-E; Green, CR-ADE.  
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Figure 15: β-Diversity of intestinal regions. Relative abundance of operational taxonomic units was 
analyzed by principal coordinate analysis using the Bray-Curtis similarity index to determine 
differences in microbial community structure according to region.  Elipses depict 95% confidence with 
respect to samples of the same region.  Communities with different superscripts are different, P < 
0.005.  Blue, lumen contents of cecum, spiral colon, or descending colon; green, cecum mucosa; red, 
spiral colon mucosa. 
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cecum, spiral colon, and descending colon were similar to one another, but distinct from 
mucosal communities of the cecum (P < 0.005) and spiral colon (P < 0.001). 
Lumen and mucosal communities of the spiral colon were compared within each 
nutritional treatment.  Differences were only detected (P < 0.05) in CD calves (data not 
shown).  Phylum assignments were given to each OTU based on consensus taxonomy 
generated in MOTHUR and phylum relative abundance was compared among lumen and 
mucosal samples from CD calves (Figure 16).  The spiral colon mucosa of CD calves was 
found to harbor increased relative abundance of Proteobacteria (P < 0.001) and decreased 
relative abundance of Bacteroidetes (P < 0.005) compared with the lumen, whereas 
relative abundance of Firmicutes remained constant.  Proteobacteria, Bacteroidetes, and 
Firmicutes comprised 18.7 and 46.8, 39.4 and 9.3, and 36.5 and 38.7% of lumen and 
mucosal communities, respectively. 
Figure 16: Phylotype relative abundance in lumen and mucosal communities of 
spiral colon in CD calves. 16S amplicons from the spiral colon lumen and mucosa of 
colostrum-deprived calves were assigned consensus taxonomy as operational 
taxonomic units with 97% similarity and classified according to phylum.  Mean 
phylum relative abundance differs between lumen and mucosa, *P < 0.005, **P < 
0.001. A, Actinobacteria; B, Bacteroidetes; F, Firmicutes; Fu, Fusobacteria; P, 
Proteobacteria; V, Verrucomicrobia; U; unclassified. 
99 
 
 
Discussion 
 To date, this study is the first to explore MAP colonization of intestinal tissues in 
calves within 14 d of age.  These results demonstrate that the organism populates distal 
regions of the small intestine in low abundance after passage of the inoculum within 5-7 
d after infection.  Calves in the present study were inoculated with two doses of 10
8
 cfu 
MAP.  In a commercial setting, calves born to infected, “super-shedder” cows are 
potentially exposed to greater than 10
7
 cfu MAP per gram of maternal feces (Behr and 
Collins, 2010)
 
and may encounter the organism in colostrum and milk (Stabel et al, 
2014).  The experimental dose is thus a high, but realistic representation of natural 
infection.  Observed shedding of the organism in feces at d 7 confirms the risk for 
horizontal transmission among newborn calves, as experimentally inoculated calves were 
previously found to shed MAP in feces around 2 mo. after infection (Mortier et al, 
2014a).  Risk of horizontal pathogen transmission among cohorts should be assessed on 
commercial operations that are considering grouped-housing scenarios in conjunction 
with automated feeders. 
 Low-abundance colonization of distal tissues in the small intestine without 
development of lesions in gut-associated lymphoid tissue agrees with previous reports of 
the course of MAP infection, which includes uptake by ileal Peyer’s patches, 
internalization by epithelial lymphocytes, and evasion of intracellular neutralization by an 
unknown mechanism (Lugton, 1999).  Detection at d 14 of MAP in tissues despite 
absence in lumen contents and feces suggests that the organism persisted in the mucosa in 
a manner independent from passive presence associated with inoculation.  Persistence of 
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the organism and replication during the subclinical stage of infection have been attributed 
to tolerance within lymphoepithelial tissues (Lugton, 1999; Harris and Barletta, 2001).    
Although no differences in infection were demonstrated among nutritional 
treatments, the TH2 aberration of cattle in the advanced stage of Johne’s disease lends to 
comparison with natural TH1 immune suppression in bovine neonates (Chase et al, 2008).  
Interferon-γ, a TH1 cytokine, is a hallmark of subclinical MAP infection and derives 
primarily from CD4
+
, CD8
+
, and γδ T cells for stimulation of phagolytic activities (Behr 
and Collins, 2010).  Progression to advanced disease, characterized by TH1 suppression, 
is partly mediated by TGF-β, which is also found in colostrum  (Behr and Collins, 2010; 
Stelwagen et al, 2009).  As reported in Chapter III, CD calves exhibited an increased 
TH1-like lymphocyte pattern in peripheral blood compared with CR calves, but the 
response to MAP in lymphoid tissues of all calves was TH2-like.  Interestingly, MAP was 
uncultured from the distal small intestine of CD calves, although low n is a limitation of 
these results such that no statistical difference was detected.  Nonetheless, these results 
support that natural immune suppression of the bovine neonate may potentiate increased 
susceptibility to MAP.  Abrogation of TH1 suppression during early life, as discussed by 
Chase et al (2008), warrants further exploration among efforts to prevent infection.   
 Manipulation of the immune bias in neonatal calves may have broader 
implications than susceptibility to a sole pathogen.  Nutritional treatments of colostrum 
and fat-soluble vitamins were hypothesized to enable calves to differentially interact with 
microbial communities in the mucosa, and that differences between mucosal and luminal 
communities would coincide with increased health.  Colostrum deprived calves 
maintained a significant difference between luminal and mucosal communities in the 
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spiral colon and a trend toward significance in the cecum, whereas these differences were 
not observed in other calves.  Combined community structure, however, did differ 
according to nutritional treatment; communities of CD and CR calves clustered 
differently, and communities of calves supplemented with vitamins D3 and E, which were 
of lowest risk for scours (Chapter II), clustered together.  With increased number of 
experimental units, differences between lumen and mucosal communities of other 
treatment groups are potentially detected, as are effects of nutritional treatments.  
Potentially different regulation of mucosal communities, however, is a fascinating finding 
in the context of poor health associated with colostrum deprivation.    
 Differences between lumen and mucosal communities were hypothesized to relate 
to increased health.  The difference, however, was observed only in CD calves, which 
contradicts this hypothesis.  When phylotype differences were examined, the mucosa was 
indeed found to harbor increased Proteobacteria, which are generally regarded as 
opportunists, and decreased Bacteroidetes.  This finding relates to increased likelihood of 
clinical scours and depression noted in Chapter II and fits the criteria for dysbiosis posed 
by Williams et al (2011).  Looft et al (2014) reported increased luminal diversity, but 
similar bacterial community structure in lumen and mucosa of the large intestine in 
swine, thus suggesting that organisms of the lumen of the large intestine are well adapted 
for post-ileal mucosal residence.  Lumen associated organisms in mature animals may 
derive from those harbored in the mucosa (Savage, 1987; Williams et al, 2011), but 
collectively, these findings indicate that disparity of lumen and mucosal communities in 
the large intestine is not associated with increased health.   
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Ileal Peyer’s patches are well recognized as sites of immune activity (Yardley et 
al, 1978; Keren et al, 1978), but amplicons of ileal origin in calves of this study were not 
sequenced to sufficient depth to allow comparison.  The previously noted hypothesis that 
the mucosa harbors organisms for inoculation of the downstream lumen may especially 
apply to the ileum.  Despite similarity between lumen and mucosal communities in other 
intestinal regions, ileal community structure differs markedly between the lumen and 
mucosa in swine (Looft et al, 2014).  Our hypothesis of nutritional enablement of 
mucosal regulation likely does not hold true in the large intestine, but requires further 
exploration in the ileum.  Lymphocytes of Peyer’s patches and the ileo-cecal lymph node 
may directly mediate tolerance to early colonizers.  Regulation of a stable mucosal 
inoculum in the ileum would be energetically favorable to the animal and consistent with 
anatomical observations; the ileo-cecal valve slows the rate of passage to allow prolonged 
interactions within approximately 20-25 cm of ileum that contain Peyer’s patches, 
whereas active regulation of the microbiota along meters of the large intestine is 
potentially less favorable.  The disparity between lumen and mucosal communities in the 
spiral colon of CD calves relates to failure of passive transfer of IgG1 and haptoglobin 
reported in Chapter II and an increased peripheral TH1-like lymphocyte profile (Chapter 
III), which suggests decreased tolerance.  The hypothesis of ileal regulation of a 
downstream inoculum can thus be developed to posit that increased TH1 immune activity 
in the large intestinal mucosa relates to decreased tolerance to the inoculum of ileal 
origin. 
Surprisingly, increased richness in the cecum and spiral colon was a featured 
characteristic of the dysbiotic events observed in CD calves.  Microbial richness in feces 
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of pre-weaned calves is known to increase through the first 7 weeks of age, with lower 
richness observed during diarrheal disturbances (Oikonomou et al, 2013).  Increased 
richness observed in CD calves can thus be considered evidence of pre-maturity.  
Potentially, increased ileal TH1 immunity limits diversity in the hypothesized ileal-
mucosal inoculum, which increases downstream opportunism in the colonic mucosa.  The 
increased richness in cecum and spiral colon in CD calves, however, could not be 
assigned specifically to the lumen or mucosa.   
Bacterial phylotypes of the spiral colon lumen in CD calves did correspond with a 
previous 16S phylogenetic survey of calf feces (Oikonomou et al, 2013).  The lumen was 
dominated by Firmicutes and Bacteroidetes, with Proteobacteria, Actinobacteria, and 
Fusobacteria represented as minority phyla.  Interestingly, phylum Actinobacteria, which 
houses both Mycobacteria and the beneficial Bifidobacteria, was nearly absent from the 
spiral colon mucosa in CD calves.  Firmicutes and Bacteroidetes were well represented in 
the lumen, but Bacteroidetes were decreased in the dysbiotic mucosa, whereas Firmicutes 
were unaffected by locale.  Bifidobacteria exhibit preferential growth on milk 
oligosaccharides in vitro (Zivkovic and Barile, 2011; Chichlowski et al, 2012), but low 
abundance of the parent phylum suggests that these bacteria are less involved in 
community structure in pre-weaned calves, which is in agreement with findings by 
Oikonomou et al (2013).  Conversely, Firmicutes are known to be stable in the intestine; 
evidence of direct vertical transmission through generations suggests host-specific 
adaptation of organisms belonging to this phylum, especially of genus Lactobacillus 
(Walter et al, 2011).  Although these results agree with previously reported findings, 
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sequencing of microbial communities in the pre-weaned, milk-fed calf should be repeated 
to verify key organisms in community structure. 
Conclusions 
 Results of the study identify colonization of MAP in the distal jejunum, ileum, 
and ileo-cecal valve, which are primary sites of intestinal immune regulation, within 14 d 
after experimental infection in neonatal calves.  Furthermore, calves infected with MAP 
shed the organism in feces within 7 d after inoculation and thus present risk of horizontal 
transmission in group-housed settings.  Colostrum-deprived calves presented with the 
lowest rate of MAP infection, but exhibited dysbiosis in the spiral colon that was likely 
related to passive transfer of immunity and the observed TH1-like peripheral lymphocyte 
profile.  Manipulation of TH1 signaling thus warrants exploration as a method of 
preventing infection in neonates, but must also be evaluated as a mediator of greater 
microbial colonization in key intestinal regions such as the ileum.  Although ileal 
communities were not assessed, immune regulation in this region may mediate survival 
of a mucosal inoculum for downstream activity in the colon.  Disparity between lumen 
and mucosal communities in the large intestine does not relate to increased health, but 
may reflect opportunism potentiated by aberrant upstream regulation.  
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CHAPTER 5 
CONCLUSIONS AND FUTURE WORK 
 
 
Conclusions 
Results of these studies support hypotheses that dietary colostrum and fat-soluble 
vitamins are key to optimal health in neonatal calves.  Non-supplemented calves fed 
PWM were deficient in vitamins D and E.  Although colostrum supplementation alone 
improved health, correction of micronutrient deficiencies by supplementation with 
vitamins D3 and E decreased the likelihood of scours among colostrum-replete calves.  
Immune components in colostrum such as IgG1 are hypothesized after extensive study to 
complement TH1 immune-suppression in the neonate, and passive transfer of acute phase 
proteins is likely of stimulatory benefit during early immune interactions.  Colostrum-
deprived calves failed to passively acquire IgG1 and haptoglobin and exhibited decreased 
peripheral abundance of γδ T cells that strongly expressed CD25, which is the 
interleukin-2 receptor.  The peripheral lymphocyte profile of CD calves indicated in vivo 
TH1 stimulation, which likely resulted from abrogated TH2 suppression.  In all calves, 
TH1-like peripheral responses to PHA were observed in vitro and included relative 
contraction of the γδ T cell subset, but TH2-like lymphoid responses to MAP in vitro 
produced γδ T cell proliferation.  The γδ T cell subset may be an essential component of 
neonatal immunity that is activated by interleukin-2 signaling and capable of response to 
Mycobacterial antigen. 
MAP was found to colonize distal regions of the small intestine including distal 
jejunum, ileum, and ileo-cecal valve, albeit low abundance.  These intestinal regions are 
thus identified as critical areas for prevention of infection.  Although ileal immunity and 
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microbial community structure were not assessed, immune regulation of a stable 
inoculum in the ileal mucosa may be affected by the neonatal TH1/TH2 balance and could 
impact early survival of MAP.  Within 7 d of experimental infection with MAP in a dose 
representative of high exposure in a commercial setting, the organism was detected in 
feces.  Thus, in a scenario of neonatal exposure to MAP, the organism infects in low 
abundance, but is largely shed within the first two weeks of age.  Infected calves present 
a risk of horizontal transmission, especially when raised in a group-housed setting. 
Nutritional treatments affected microbial community structure in a manner 
consistent with clinical observations of health.  Colostrum-deprived calves harbored 
collective microbial communities that were different from communities of calves fed 
colostrum.  Similarly, communities of calves supplemented with vitamins D3 and E, 
which were of the least likelihood of presenting with scours, were similar to each other. 
Increased richness of communities of cecum and colon in CD calves did not relate to 
increased health, but instead suggests prematurity, as Proteobacteria were favored in the 
spiral colon mucosa at the expense of Bacteroidetes.  The difference between the spiral 
colon lumen and mucosa was characterized as dysbiosis, and suggests that tolerance is 
the large intestine is demonstrated by increased similarity between the lumen and 
mucosa.  Tolerance in the hindgut may be related to increased regulation in the ileum, but 
ileal amplicons were not sequenced in sufficient depth to allow for this comparison, so 
this hypothetical relationship warrants further exploration.  In conclusion, colostrum 
deprivation abrogates TH2-biased neonatal immunity to alter microbial community 
structure in the bovine intestine. 
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Future Work 
 Much of what has been determined by these studies is suggestive of improved 
health in response to colostrum and vitamin supplementation, but conclusions from these 
works yet require confirmation.  Passive transfer of haptoglobin is hypothesized to occur 
as a result of colostrum ingestion by the neonate, but hepatic synthesis of the molecule 
should be quantified to demonstrate a null effect of colostrum supplementation on an 
endogenous acute phase response.  The role of haptoglobin in early immunity should be 
further explored to determine if passive transfer of the molecule enhances memory 
responses to antigen.  Similarly, γδ T cell-mediated immunity should be explored in vitro 
in a controlled TH2 environment.  Findings in this regard may be readily researched in a 
colostrum-deprived calf model to further characterize abrogations to the natural, immune-
suppressed state of the neonate, and to further reveal opportunities for manipulation of 
cell-mediated immunity to enhance health and survival of pre-ruminant calves. 
 The characterization of colonic microbial colonization provided in this study 
suggests that disparity between lumen and mucosal communities in the hindgut is not 
favorable to neonatal health.  The observed dysbiosis was a result of the colostrum-
deprived treatment, which suggests aberration of an endogenous regulatory mechanism in 
these calves.  Achieving deep sequence data in the calf ileum, which is a more likely site 
of endogenous, immune, regulatory activity, may provide insight to the mechanism of 
colonic dysbiosis.  More important than characterization of the intestinal microbial 
community of calves is establishment of a conceptual framework of the internal 
regulatory mechanisms that govern colonization.  Manipulation of neonatal immunity is 
perhaps a key component in fostering life-long health and productivity.  
